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Abstract
Problem: The most recent data from the Centers for Disease Control and Prevention (CDC,
2018b) suggest that 130 Americans die from an opioid overdose each day, thus creating an
unprecedented number of opioid-related deaths in the United States to date.
Context: Of particular interest to the author and this DNP project is that Veterans are twice as
likely to die from an opioid overdose, compared to the average American, making this epidemic
a priority for Veterans Health Administration (Wilkie, 2018).
Interventions: The author developed a 9-session Opioid Safety Shared Medical Appointment
(SMA) program to reduce opioid reliance in Veterans using an 8-member interdisciplinary team.
Comparisons were made of 90 participants who received training via Cohort I, comprised of 30
participants led by a patient-aligned care team (PACT) that met monthly over 9 months and
included health coaching, to Cohort II, comprised of 30 participants led by a PACT team that met
weekly over 9 weeks and excluded health coaching, to Cohort III (control), comprised of 30
participants who received training via routine, status quo, in-office education. The curriculum
was based on a whole health model and introduced self-care modalities and opioid safety
education. A comprehensive whole health toolkit was developed containing resource materials
and educational handouts for Veterans to use throughout the course of the opioid SMA.
Outcome Measures: Outcome measures for evaluation of this evidence-based project include
morphine equivalent daily dose (MEDD), pain scores, and use of complementary alternative
modalities (CAMs).
Results: Data analysis revealed the only cohort with a statistically significant reduction in
MEDD was Cohort I with health coaching (p < 0.0064). Cohort II (without health coaching) did
not have a significant reduction in MEDD (p < 0.64), but did have a significant reduction in pain
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scores (p < 0.02) and a significant increase of CAMs (p >.01). Cohort III (control group in-office
education) did not have a significant reduction in MEDD (p < 0.88) or pain scores (p < 0.26) and
had no significant increase in the use of CAMs (p < 0.33). However, findings of this work across
all three cohorts included clinically significant improvements in MEDD, pain scores, and use of
CAMs.
Conclusions: Using whole health SMAs may provide an effective, evidenced-based, costeffective approach to managing chronic pain, decreasing MEDD and pain scores, and increasing
CAM use among Veterans. While results support the clinical significance of this model, findings
warrant additional investigation.
Key words: opioids, Veteran, Veterans Administration, reliance, whole health, shared medical
appointments
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Introduction
Problem Description
The setting for this quality improvement (QI) project was the primary care (PC)
outpatient clinic in a large tertiary Veterans Administration (VA) healthcare facility located in the
state of Alabama, providing care for approximately 65,000 Veterans each year, with
approximately 85,000 outpatient visits. All patients seen at the VA are adults, with a mean age of
65.5 years.
Opioid prescribing for the treatment and relief of chronic pain has risen precipitously
over the last several decades, escalating the death toll of Americans dying from an opioid
overdose to approximately 130 per day (Centers for Disease Control and Prevention [CDC],
2018b). In 2017 alone, more than 70,000 Americans died due to drug overdoses, which included
both illicit drugs and legally prescribed opioids (National Institute on Drug Abuse [NIDA],
2019). The United States opioid crisis has reached critical mass, with approximately 4% of U.S.
adults consuming opioids for chronic pain relief (Clark & Schumacher, 2017). Chronic pain has
been reported by 50% of Veterans using the VA healthcare system (Gellad, Good, & Shulkin,
2017).
To illustrate the magnitude of the problem on a local level, in 2017, Alabama providers
wrote 107.2 opioid prescriptions for every 100 persons, the highest prescribing rate in the nation,
and almost twice the average U.S. rate of 58.7 prescriptions (NIDA, 2019). The State of Alabama
experienced an 11% increase in death rates from opioids from 2016 to 2017 (NIDA, 2019). The
latest available data at the facility where the study was conducted reported 12% of Veterans are
on prescribed chronic opioids (Slack, 2018). VA patients on long-term opioids are required to
sign an informed consent form for long-term opioid use (U.S. Department of Veterans Affairs,
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2020). Included in the consent is information on the risks of long-term opioid use and the
requirement for the Veteran to provide monthly urine drug screens. In the event a Veteran’s urine
drug screen contains illegal substances, the prescriber is required to immediately address the
safety concerns regarding mixing illegal opioids with prescribed opioids. This change of practice
DNP project was selected because healthcare teams and individual clinicians have been seeking
solutions to end the opioid crisis, with limited success.
Although the national focus has been placed on identifying the cause of the opioid
epidemic, little success has been achieved at developing a comprehensive approach to reducing
reliance on powerful and addictive pain medications. Looking at the magnitude of this crisis, in
2017, illicit and prescribed opioids were responsible for 47,600 overdose deaths in the United
States, 67.8% of all overdose deaths (CDC, 2017). Opioids have now surpassed firearms as the
leading cause of accidental deaths in the United States (Siegel, 2018). Furthermore, Dasgupta,
Beletsky, and Ciccarone (2018) reported that the United States and Canada lead the world in the
highest per capita opioid consumption, with 41% of overdoses occurring in urban counties, 26%
occurring in the suburbs, 18% occurring in small metropolitan areas, and 15% occurring in rural
areas. In 2017 alone, an estimated 17.4% of the U.S. population was prescribed one or more
opioids, with the average person receiving 3.4 prescriptions (CDC, 2018a). This evidence
highlights the urgent need for a solution to the unacceptable opioid crisis facing our nation.
Earlier methods to address the opioid crisis, such as forced reductions, have been found
to produce counteractive and unsafe results, necessitating alternative approaches to decrease
opioid reliance (Joseph, 2019). Much debate and blame have transpired regarding how our nation
ended up in an opioid crisis. To date, sustainable approaches to effectively reduce opioid reliance
remain elusive.
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To move toward a safer and patient-centered approach to reduce opioid reliance and
improve the patients’ quality of care, an interdisciplinary team brought together two emerging
and effective modes of care. The whole health model was used within the context of a shared
medical appointment (SMA) with a group of Veterans derived from a single provider’s panel of
patients. An SMA is a medical appointment where patients are seen by clinical staff in a group
setting that combines education and discussion regarding self-management of a chronic
condition or disease (Omogbai & Milner, 2018). The SMAs were 90-minute appointments and
included opioid safety education using whole health concepts.
Available Knowledge
PICOT Question
Melnyk, Ford, and Overholt’s (2017) intervention template was used to develop the
following population, intervention, comparison, outcome, time (PICOT) question for this change
of practice DNP project: (P) For Veterans reliant on opioids, (I) what is the effect of shared
medical appointments, with a full patient-aligned care team using a whole-person health
approach and health coaching on opioid usage, pain scores, and use of complementary
alternative modalities, (C) compared to education via office visits (T) over 12 months?
Search Methodology
The literature review to support this project was conducted from February 2019 to March
2020. To ensure the strongest and most relevant evidence, 90 articles were reviewed using the
Johns Hopkins Nursing Evidence-Based Practice Guidelines and scoring system (Dang &
Dearholt, 2018). This tool appraised the strength and quality of evidence found in each study and
helped determine the inclusion and exclusion criteria for addressing the author’s evidence-based
practice question. The inclusion criteria included full-text articles, published in English, from
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2014 to 2019. The search yielded 15 studies, which included research, non-research, and
supportive studies (one editorial) that provided statistics and evidence on the opioid crisis. The
articles were chosen based on their relevance to the QI topic and the strength of their evidence.
To gain the strongest evidence, multiple databases were searched and included the Cochrane
Library, PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL)
databases and evidenced-based journals. The search used the following keywords: opioids,
reliance, whole health, group appointments, and Veterans. Inclusion criteria included articles
from 2005 to 2020 from peer-reviewed journals and published in the United States. Exclusion
criteria included book chapters and articles outside the United States.
Summary of Evidence
After reviewing the abstracts, 73 articles were excluded that failed to align with the
study’s scope and relevance. The final literature selection criteria were determined after
reviewing the strength, weaknesses, limitations, and quality of the evidence; 15 articles
demonstrated the best possible evidence upon which this intervention was based. The search
resulted in four Level II A/B, seven Level III A/B, one Level IV A/B, and three Level V, A
studies. The search revealed a noticeable gap in the literature pertaining to the use of a whole
health approach and SMAs to address the opioid crisis or to decrease opioid usage in the Veteran
population. Therefore, most articles were qualitative and geared toward QI initiatives and
statistical data regarding the opioid crisis. A summary of results from the appraised evidence is
included in an evaluation table (see Appendix A). Three themes emerged from the summary of
evidence in the review of articles and research studies: (a) impact of the opioid crisis, (b) use of
SMAs in clinical settings, and (c) past approaches and modalities to address the opioid crisis.
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Impact of the opioid crisis. From 1999 to 2014, nearly 400,000 Americans died from an
opioid overdose, including prescription and illicit opioids (CDC, 2017). The estimated total
economic burden of prescription opioid misuse in our nation has skyrocketed to $78.5 billion
annually, which includes the cost of healthcare, addiction treatment, lost productivity, and
criminal justice involvement (CDC, 2017). The following review of the literature depicts the
extent of the opioid crisis and genesis of the crisis.
Tyndale and Sellers (2018), nationally recognized experts, opined based on experiential
evidence that prescription opioid sales in the United States nearly quadrupled from 1999 to 2014,
without a significant change in the amount of pain reported by Americans. The United States is
the leading nation for the highest rate of opioid prescribing. The rapid rise in opioid overdose
death rates in the United States was driven by three separate waves of lethal drugs. The first
wave of prescription opioid mortality started in the late 1990s, followed by a second wave of
deaths from heroin starting in 2010, culminating in the current third wave of deaths due to
synthetic opioids, which include illicit fentanyl and fentanyl analogs (Tyndale & Sellers, 2018).
Tyndale and Sellers point to the urgent need for more leadership and funding to find an
evidence-based solution to the opioid crisis.
In an integrative review conducted by Chen, Shiels, Thomas, Freedman, and Berrington
(2018), a comparative analysis of data from 13 countries of premature mortality from drug
overdoses was reviewed. Using the World Health Organization’s mortality database to collect
the yearly number of deaths due to drug overdoses, the search was limited to adults aged 20 to
64. Findings indicated the U.S. opioid overdose death rates were more than twice the number of
those in any other country. Overdose death rates were highest for men in the 35- to 49-year age
group and for women ages 50 to 64 years. Drug overdose deaths more than doubled in the 21st

WHOLE HEALTH OPIOID SAFETY PROJECT

13

century, with an estimated 63,632 deaths in 2016. This study’s limitations included restrictions to
those countries with the highest quality data, differences in coding practices, and the inability to
compare the contributions of specific drugs to mortality death rates of each country (Chen et al.,
2018).
To further illustrate the magnitude of the problem, New Jersey’s Governor Christie led a
commission to assist the President in developing recommendations to combat the opioid crisis, to
include a national curriculum to educate prescribers on standards of care for administering
opioids. Through subject matter expert interviews and testimonies, the governmental consensus
panel determined that a multi-pronged approach is needed to address our nation’s opioid crisis.
Mental health services in our nation are lacking, as only 10.6% of youth and adults in the United
States who need treatment for opioid addiction are receiving it (Christie et al., 2017).
Recommendation strategies to reduce the opioid supply of illegal drugs into the United States
include improved collaboration and information sharing between law enforcement agencies to
target the supply chains (Christie et al., 2017). The illegal entry of opioids into our nation has
contributed to the overall crisis and must be addressed. The commission’s recommendations
apply to both the Veteran and non-Veteran population who consume illegal opioids and supports
the use of an interdisciplinary whole health approach to combat the opioid crisis.
To highlight the extent of the opioid crisis, Han et al. (2017) discussed findings from the
National Survey on Drug Use and Health of non-institutionalized American adults (n =51,200)
who reported opioid use. The purpose of this labor-intensive, in-person, qualitative study,
conducted by the Substance Abuse Mental Health Services Administration, was to measure
prescription opioid use, misuse, use disorders and motivation for use. Survey results revealed
that 37.8% of U.S adults used prescribed opioids, 4.7% misused opioids, and 0.8% had an opioid
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use disorder. The purpose of this study was to link use disorders to economic and behavioral
health issues, as misuse was most commonly reported in high-risk individuals, such as the
uninsured, unemployed, low income, or those with a mental health history (Han et al., 2017). As
discussed previously, Veterans are included in this at-risk population.
Edmond et al. (2018) conducted a cross-sectional survey (n = 460) over 12 months to
examine rates and correlations of non-pharmacological modalities (NPMs) use in Veterans
during recent Middle Eastern conflicts. This qualitative study’s findings with meta-synthesis
included 43.7% of male Veterans and 56.3 % of female Veterans who had received care in PC
settings reported chronic pain. Most Veterans reported using a minimum of one NPM within the
past 12 months of the survey. A major limitation of this study was the lack of measurement of
the effect of the NPM on Veteran pain levels. This study’s findings can be used to tailor pain
management strategies using NPM of the patient’s choice.
Nahin (2018) conducted a qualitative study of data extracted between 2010 and 2014
from the National Health Interview Survey (NHIS) Sample Core and the NHIS Adult
Functioning and Disability Supplement. This labor-intensive survey (n = 67,696) compared pain
levels in a population of Veterans (n = 6,647) and non-Veterans (n = 61,049). Survey
participants with severe pain were identified by a validated pain severity system that was part of
the NHIS Adult Functioning and Disability Supplement. Veterans are generally considered
healthier than the average citizen upon entering active duty due to the rigorous physical and
mental health screening requirements to join the service. While serving, active duty military are
considered high risk for combat and non-combat related injuries and are frequently exposed to
both environmental and mental stressors. Results revealed that more Veterans (65.6%) than nonVeterans (56.4%) reported pain in the three months before the time of the survey. The percentage
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of severe pain was also higher in Veterans (9.1%) versus non-Veterans (6.3%), particularly those
who had served in recent military conflicts. The study findings did not link specific causes for
increased pain levels in Veterans compared to non-Veterans and did not offer a risk-mitigating
strategy for the Department of Defense consideration. The study findings reflect the need for
revised pain management strategies in the outpatient setting, especially for the Veteran
population.
Although most of the information reviewed by the author regarding the impact of the
opioid crisis was found in recommendations, qualitative studies, and QI studies, the data
supported an immediate need to find a solution to the opioid crisis in the Veteran population.
SMAs in clinical settings. In a prospective study, Romanelli, Dolginsky, Byakina,
Bronstein, and Wilson (2017) demonstrated the benefit of SMAs for addressing various chronic
medical conditions, including chronic pain. Survey data from 130 patients who attended SMAs
showed improvements in patients’ confidence levels to manage their pain and their healthcare
team’s ability to assist them in managing their pain. Overall, satisfaction with attending the SMA
was 81%. The authors discussed the positive impact SMAs have on improving patient
satisfaction, increasing connectivity with the clinical care team, resiliency, and facilitating care
coordination. This study reflects the value of SMAs in promoting opioid safety and awareness,
along with shared decision-making with the patient’s healthcare team. Romanelli et al. noted that
the use of SMAs in PC clinic settings increases however, a standardized approach to
implementing SMAs is needed and supports this change of practice DNP project.
Several studies evaluated the impact of SMAs on patients with diabetes. The strongest
evidence to support practice changes in the use of SMAs was found in work done by Drake,
Meade, Hull, Price, and Snyderman (2018). Their quasi-experimental study reviewed survey data
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(n = 12) from Type II diabetes mellitus patients who attended eight SMAs over seven months.
The study reviewed the feasibility of incorporating personalized health planning into SMAs and
collected qualitative data from focus groups, patients, and clinical staff. Clinical outcomes
included reductions in hemoglobin A1C, low density lipoprotein, body mass index, blood
pressure and an increase in achievement of health goals. The use of personalized health planning
in SMAs in the clinical setting shows great promise in helping the patient and healthcare team
identify health goals and plan a delivery of care that is patient-centered.
In a QI study by Omogbai and Milner (2018), SMAs were launched for a group of
Veterans with diabetes. The VA reported the diabetic population to be at 24%, compared to the
national average of 9%. This qualitative study involved male Veterans (n = 30), with a mean age
of 64.7 years (SD = 5.36), who attended an SMA from October 15, 2015, to March 15, 2016. The
following clinical data points were assessed: A1C, blood pressure, total cholesterol, HDL, LDL,
triglycerides, body mass index, and VA hospitalizations. At the end of the SMA, a decrease was
observed across the three data points of blood pressure, total cholesterol, and triglycerides, with
only minimal changes in the mean HDL levels. This study supports the use of SMAs to impact
clinical outcomes positively.
In a systematic review of 17 randomized control trials and nonrandomized clustercontrolled trials, Edelman et al. (2012) found significant improvements in patients’ clinical
outcomes after attending SMAs; outcomes included hemoglobin A1C (-0.55 percentage points
{95% CI, -0.11 to -0.99} and improved systolic blood pressure (-5.2 mmHg {95% CI, -3.0 to 7.4}; however, there was not an improvement in low density lipoprotein cholesterol (-6.6 mg/dl
{95% CI, 2.8 to 16.1}. This study indicates that SMAs can be a useful approach to impact
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clinical outcomes among patients with diabetes and supports their use for other clinical
conditions.
In a pre-post cohort, QI study at two VA facilities with PC clinics, Cain et al. (2017)
sought to improve hypertensive VA patients’ (n = 21) access and quality of care through their
participation in pharmacist-led SMAs. The aim was to decrease blood pressure and improve
medication adherence for those Veterans attending a pharmacist-led SMA. The study’s findings
showed that the Veterans who attended a pharmacist-led SMA had significant reductions in
systolic blood pressure; however, the medication adherence did not change significantly from
baseline. This study suggests a strong linkage between education in group settings over
individual office appointment education. SMAs could easily be replicated for various other
health conditions in other healthcare settings.
Wadsworth et al. (2019) conducted a systematic review without meta-analysis of 1,359
papers, qualitative studies, and quantitative studies, comparing outcomes from patients who
attended SMAs versus those who had received in-office visits. Overall results indicated positive
patient-provider qualitative advantages over in-office visits to include improved communication
time with their provider. Wadsworth et al. noted that patients reported being more satisfied with
their care after attending SMAs versus the care they received during in-office visits in multiple
qualitative studies. Patients perceived providers were less hurried during SMAs than in regular
office visits. The authors pointed out that the use of SMAs is increasing in popularity in primary
care settings, yet a gold standard for conducting an SMA does not yet exist, which supports the
need for further study.
Each of the above studies using SMAs positively impacted the participants’ health
outcomes and supports the use of SMAs in decreasing opioid reliance in the Veteran population.
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Past approaches and alternative modalities. Nationally, numerous approaches to
combating the opioid crisis have been explored. Complementary and alternative modalities
(CAMs) exist to assist individuals reliant on opioids to find alternatives to taking opioids for pain
relief. CAMs, such as mindfulness, acupuncture, tai chi, and meditation, help provide patientcentered treatments and present palatable alternatives for the patient reliant on chronic pain
medications.
In a qualitative factor analysis observational study, Betthauser et al. (2014) reviewed
interviews and surveys from Veterans (n = 97) at a VA facility to assess their acceptability of
CAM, conventional medicine, mind-body integration, and belief in CAM. Previous Veteranfocused studies found that 23% to 50% of Veterans utilize some form of CAM, and those not
currently using CAM would be open to using a CAM, if it was made available to them. Findings
from this study included the Veterans’ acceptability for using CAMs as an effective means to
maintain health. Veterans who reported current CAM use endorsed the following modalities:
spirituality/prayer (39%), meditation/yoga/relaxation/imagery (21%), herbal/botanical
supplements (19%), and dietary (19%). The most frequently used CAM was massage, at 61%.
This study underlines the importance of assessing Veterans’ willingness to explore CAM options
as alternatives to pain medications.
In a systematic scoping review with meta-analysis, Rani, Johnston, Bormann, Hull, and
Taylor (2014) reviewed the literature from 1976 to 2014 to determine the Veterans and active
duty personnel’s mind-body practices to determine gaps in the literature regarding CAM usage in
this population. The most observed practices were meditation (n = 25), relaxation exercises with
imagery (n = 20), physical therapy and spinal manipulation (n = 16), and acupuncture (n = 11).
Recommendations were made for further research on the most frequently used CAMs to improve
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Veterans and active duty personnel’s health. These findings support the effectiveness of CAMs
for Veterans and active duty personnel in developing whole health treatment plans in the PC
setting.
Frank et al (2017), in a systematic review with randomized control trials with metaanalysis, synthesized the effectiveness of methods to decrease long-term opioid therapy (LTOT)
for chronic pain in U.S. adults. The patient outcomes assessed were the severity of pain, quality
of life, function, withdrawal symptoms, substance abuse, and adverse events. Findings included
that pain levels and quality of life functions may improve both during and after opioid reduction.
Data synthesis was completed of 67 studies, including 11 randomized control trials and 56
observational studies. Opioid tapering was reported as challenging for both the clinician and the
patient, with routine discontinuation ranging between 8% to 35%. In one survey of patients on
LTOT, approximately 50% of patients verbalized a desire to cut down or discontinue their opioid
use; however, 80% were still being prescribed high-dose opioids one year later. In patients who
had a non-fatal opioid overdose, 91% remained on opioids after the overdose. Little evidence
exists to help clinicians safely guide patients through the process of tapering off LTOT,
especially in the PC setting, where the majority of LTOT is prescribed. Care provided by
multidisciplinary teams, along with close follow-up, was noted as positive attributes of programs
evaluated in this study. This systematic review underscores the importance of physicians
discussing the risks and benefits of tapering LTOT and referring patients to multidisciplinary
pain teams for additional support while decreasing their usage of opioids.
In synthesizing the evidence from literature review, no single approach emerged related
to using a whole health approach to decrease opioid reliance. However, the positive patient
outcomes that occurred with past diabetes mellitus and hypertension SMAs support the need for
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immediate practice change for implementation in the PC setting to reduce opioid usage. The
literature review clearly depicted the medical, financial, and psychological impact of opioid
reliance and supported finding a risk mitigating approach. Additionally, the evidence
demonstrates that SMAs are superior over in-office education. The author found it remarkable
that literature review yielded zero evidence of past practices for using SMAs to reduce opioid
reliance. Although literature review added significant value to the body of evidence regarding the
opioid crisis and causative factors, further study is needed to fill the gap between identification
of the problem of opioid reliance and the solution for a practical, cost-effective, and sustainable
approach for managing chronic pain.
Rationale
Two theoretical frameworks heavily influenced the development and interpretation of this
project, including Pender’s (2011) health promotion model (HPM) and the VA’s proactive health
and well-being model (Gaudet & Kligler, 2018).
Pender’s Health Promotion Model
A commonly used behavioral change model, Pender’s (2011) HPM uses social cognitive
theory and its factors (perceived strengths, barriers, self-efficacy) to influence engagement in
health promoting behaviors, such as reducing reliance on opioids. The model assumes that
individual differences (i.e., demographics, personality), interpersonal influences, and behavioral
and environmental factors interact with each other to influence the cognitive, motivational
processes requisite for behavior change. Five core concepts, including person, environment,
nursing, health, and illness, comprise the model and provide rich sources of interventional
content and strategies, including specific, measurable, achievable, realistic, and timely (SMART)
goal setting. The use of SMART goals proved to be an integral component of this DNP project.
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The concept of self-efficacy—a person’s belief in his/her capacity to execute behaviors
needed to produce specific performance attainments (Bandura, 2013)—also heavily influenced
this project, secondary to its temporal implications for behavioral change. For example,
developing self-efficacy requires reinforcement (i.e., behavioral feedback) for approximated
behavior over time (Bandura, 2013). Over iterations of positive behavioral feedback (i.e.,
positive or negative reinforcement) for applying new information/knowledge, self-efficacy grows
as behavior improves, and behavior improves as self-efficacy increases. This behavioral process
resulted in the team’s decision to change the frequency of SMAs from monthly to weekly.
The HPM model was chosen for this DNP project as each of the principles, including
self-efficacy, aligned with the SMA opioid safety program’s whole health concepts.
Additionally, the concepts guided each phase of this QI study by focusing on how they are
interrelated to achieve optimal health by selecting healthy behaviors. Pender’s (2011) HPM had
applicability in the development, implementation, and aim of this QI study.
Veterans Administration’s Proactive Health and Well-Being Whole Model
Also with origins in health promotion theory, the second theoretical framework used in
this QI project was the VA’s Proactive and Well-Being Model (see Appendix B), which outlines
the eight dimensions of health and served as the underpinning for this QI project (Simmons,
Drake, Gaudet, & Snyderman, 2016). This model moves beyond the traditional disease model,
which centers on “What’s the matter?” to a broader question of “What matters most?” (Gaudet &
Kligler, 2019). These alternative conversations with Veterans with chronic pain help healthcare
staff gain a broader view of how pain interferes with patients’ goals. At this juncture, the
healthcare team can truly begin to partner with the Veterans in helping them connect how their
present behaviors may be working against them in achieving their whole health goals.
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Gaudet and Kligler (2019) discussed the 15-year history of integrating a new paradigm of
whole health in the VA. The VA’s Office of Patient-Centered Care and Cultural Transformation
(OPCC & CT) researched and evaluated this transformation from the usual endpoints of reduced
indications of disease to the measurement and collection of well-being outcomes. According to
Gaudet and Kligler, to achieve this major change, the VA system has adopted a whole health
strategy, which includes addressing practices of the Veteran, their family, and the community,
along with social determinants. The authors stressed the importance of assessing specific
outcome data to determine when a true transformation has occurred related to the Veterans’
health and well-being. Through motivational interviewing and shared goal setting, the healthcare
team can assist the Veteran set SMART goals directed at facilitating movement toward the
Veteran’s unique mission, aspiration, and purpose (Gaudet & Kligler, 2019).
In this study, health coaching and facilitation of shared SMART goals, within the SMA
confines, assisted Veterans in addressing a broader array of health and life issues and potentially
improving their quality of life and reliance on opioids. The whole health model was chosen for
this DNP project based on its direct applicability in the SMA curriculum development and
implementation.
Specific Aim
This change of practice DNP project was completed in September 2020. This QI study’s
specific purpose was to assess the impact of SMAs on morphine equivalent daily dose (MEDD),
pain scores, and use of CAMs for managing pain. SMAs were used to introduce concepts of selfcare, opioid safety education, and goal setting.
AIM Statement

WHOLE HEALTH OPIOID SAFETY PROJECT

23

The overarching aim of this project included: By September 2020, 30 Veterans at the VA
project site who participated in a 9-month whole health opioid safety SMA led by patient-aligned
care team (PACT) staff to include a health coaching component, will have a 10% or greater
decrease in the MEDD, decreased pain scores, and a 10% increase in the use of CAMs for pain
management. This will be compared to 30 patients who participated in a 9-week whole health
opioid safety SMA led by PACT staff without health coaching, compared to 30 Veterans who
received standard, in-office education. An outline for the course curriculum delineates the
differences between the composition of the three cohorts (see Appendix C).
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Methods
Context
A whole health SMA opioid safety program was developed to assist Veterans decrease
their MEDD and pain scores and increase their use of CAMs. This QI study was launched at a
tertiary outpatient VA healthcare facility in the southern United States to answer our nation’s call
to assist Veterans decrease their opioid reliance. A 9-week opioid safety program was
implemented, comprised of 90-minute weekly appointments, known as SMAs, using a whole
health framework. SMAs are also referred to as group appointments, which combine a medical
appointment with education and discussion regarding self-management of a chronic condition or
disease (Omogbai & Milner, 2018). The SMA was designed as a single, 90-minute appointment.
Each SMA began with obtaining verbal consent from each Veteran.
Stakeholders. A stakeholder analysis was conducted to prioritize the top four
stakeholders involved in implementing this DNP project: Veterans on chronic opioids at a large
urban VA, PC teams at the VA, external PC teams, and the project site’s executive leadership
team (ELT). The author believes the most likely element at the project site that influenced and
supported this DNP project was stakeholder awareness of the urgent need to find a solution to
ending the opioid crisis among Veterans. Each stakeholder group was aware and open to the need
for change from the status quo opioid safety education delivery mode. Specific considerations for
each group are described below.
Veterans. For Veterans on chronic opioids at the project site, the major perspectives
included the Veterans’ anticipation and excitement of finding an approach to choose how to
reduce their reliance on opioids, while still managing their pain. The Veterans’ perspectives were
key to program implementation, as without their voluntary participation, belief in the program,
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and ability to make behavior changes, the program would have failed. An added advantage of the
innovation was the pre-established connectivity between the Veteran and their PC team who
conducted the SMAs. The Veterans’ agreement to participate in this voluntary program was a
testament to their vested interest in making behavior changes, such as reducing their opioid
reliance and reflecting the shared decision-making power between themselves and their PC team.
The group of stakeholders’ strategic approach included partnering with their PC team to
determine alternative modalities to control their pain.
Internal Primary Care Teams. The major perspectives of PC teams at the project site
included excitement about the possibility of implementing the same approach as their co-workers
in finding an alternative approach to decreasing their Veterans’ reliance on opioids, while still
managing their pain. To connect with this group of stakeholders, patient-care outcomes and
program successes of prior SMAs conducted by PC teams they work with were shared to build
enthusiasm and to gain potential participation in the program. To further connect with this group
of stakeholders, they were provided the opportunity to attend a 3-day opioid safety miniresidency provided by the implementation team to gain insight into running their SMA, which
included in-depth instructions, lessons learned, and resources to begin their program. The type of
power for this group of stakeholders was one of shared power, in that the program empowered
them to meet a need they had to assist their Veterans decrease opioid reliance. The project site’s
PC teams’ strategic approach was to partner with PC teams they knew had an innovative
approach that produced promising outcomes in opioid reduction using whole health concepts.
External primary care teams. The external PC team stakeholders’ major perspectives
included their interest and curiosity regarding what the VA had implemented that could assist
their patients to decrease their reliance on opioids, while still managing their pain. The
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participation of external PC teams in the program was instrumental in program spread and has
the potential to answer our nation’s call to end the opioid crisis. Connections were made with this
group of stakeholders, to include poster presentations, public presentations, journal articles, and
publications, including the American Hospital Association’s Opioid Stewardship Implementation
Guide. Additionally, this group of stakeholders was provided the opportunity to attend a 3-day
opioid safety mini-residency provided by the implementation team to gain insight into how to
run their SMA, includjng in-depth instructions, lessons learned, and resources to begin their
program. Like the project site’s PC teams, external PC stakeholders held shared power, in that
the program offered to meet a need they had to assist their Veterans decrease opioid reliance. The
strategic approach of external PC teams was to partner with the implementation team to learn
about the innovative approach that produced promising outcomes in opioid reductions using
whole health concepts.
Executive leadership team. The major perspectives of the project site’s ELT
stakeholders included their willingness to provide their support in terms of resources and
encouragement for making this innovation successful. Their ongoing support from day one was
key to program implementation to align time and resources for both conducting SMAs and miniresidencies. To connect with this group of stakeholders and garner ongoing program support,
frequent briefings were given to share program outcomes and successes. The implementation
team recently participated in a video highlighting the team’s work with reducing opioid reliance
in the Veteran population, as an example of work being accomplished to become a high
reliability organization. The project site’s ELT held positional power over the implementation
team. The group of stakeholders’ strategic approach was to provide ongoing support of the
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needed resources of time, space, and personnel to continue this successful, innovative program in
helping Veterans and other Americans reduce their opioid reliance.
After prioritizing the project’s stakeholders, a power analysis (Grace, 2017) versus
interest review was completed to categorize each group based on their power and interest over
this project. The Veterans and ELT stakeholders were categorized as high power, high interest,
indicating they needed to be managed closely, with the greatest efforts to satisfy them. The
project site’s PC teams and external PC teams were categorized as low power, high interest,
indicating they needed to be kept informed and communicated with often to ensure no major
issues were experienced.
Future plans to influence the VA culture and external healthcare systems to make it open
and receptive include promoting the ease of program implementation, sharing our team’s
expertise and resources by invitation to participate in a mini-residency, and sharing the outcomes
and successes of prior SMAs.
Interventions
The author held primary responsibility for all portions of this DNP change of practice
project, which took place between February 2019 and December 2020. The author worked
closely with an interdisciplinary team at the project site, to include the PC physician and
pharmacist who managed the participants MEDD throughout the project.
Shared medical appointments. The first intervention chosen by the author for this project
was to evaluate outcomes from Veterans who attended opioid safety SMAs, consisting of nine
sessions led by two different PACTs, compared to outcomes from Veterans receiving the status
quo, in-office education only. This evidence-based intervention was chosen to determine the
clinical efficacy and impact of delivering opioid safety education via SMAs over traditional in-
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office education. Healthcare staff involved in this project came from different backgrounds, held
different beliefs, and were racially diverse.
The original SMAs were led by Cohort I, comprised of a complete PACT, including a
physician, registered nurse (RN), licensed practical nurse (LPN), and medical service assistant
(MSA). The facilitator coordinated the SMAs, secured the meeting location, facilitated the data
collection tools, and determined topics for the each SMAs’ education portion. Additional
interdisciplinary staff (dietician, social worker, psychologist, pharmacist) were consulted and
used as subject matter experts throughout the SMA course. Cohort I met monthly over a 9-month
period and included health coaching as part of their curriculum to assist the Veterans formulate
SMART whole health goals. Cohort II was led by a complete PACT who met weekly over a 9week period and did not include health coaching. Both Cohort I and Cohort II followed a
curriculum based on the whole health model and included opioid safety education during each
session. Intermittent education was also provided to Cohort I and Cohort II in specific areas
related to self-care by interdisciplinary staff. Didactic teaching sessions, utilizing multimedia and
short training videos, were used by Cohort I and Cohort II to promote discussion and selfreflection. Educational materials were provided to both cohorts by the VA’s OPCC & CT,
including the Wheel of Health and eight dimensions of self-care. Integrative healing modalities
were introduced during the SMAs, such as mindfulness, tai chi, yoga, and physical therapy.
Cohort III was comprised of 30 Veterans receiving in-office, status quo opioid safety education
over nine months by the provider, without a full PACT, health coaching, or educational materials,
or the use of a whole health curriculum.
Toolkit. The second intervention included developing a whole health comprehensive
toolkit containing resource materials and educational handouts for Veterans to use throughout the
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opioid safety SMA. The author chose the toolkit based on the need to consolidate handouts and
educational materials to guide Veterans through each SMA session and provide a standardized
approach for other PACTs to use. A copy of the toolkit index is included as Appendix D. The
toolkit was comprised of materials supplied by the VA’s OPCC & CT, along with educational
materials prepared by subject matter experts for in-class instruction. For example, the content
included agendas for each class, ground rules, and listings of additional resources for participants
to access, such as video links for tai chi and yoga demonstrations. The toolkit was posted on the
project site’s SharePoint and made accessible for other teams to conduct SMAs.
Gap Analysis
The desired state of finding a safe and effective approach to decreasing opioid usage in
the Veteran population is clearly supported in the literature. The VA’s current approach for
decreasing Veterans’ chronic use of opioids includes adherence to a four-pronged strategy that
includes education, pain management, addiction and treatment, and risk mitigation (Gellad et al.,
2017). However, a review of the literature identified a noticeable gap between the VA’s strategy
to address the opioid crisis affecting the Veteran population and a patient-centered whole health
(holistic) approach to reducing usage, while managing pain (see Appendix E). To address the
gap, specific interventions were put into place, including developing and implementing a ninesession whole health curriculum of SMAs on opioid safety in PC clinics at the author’s site. Each
session included a component on opioid safety and focused on one of eight dimensions of whole
health.
The sessions for Cohort I were conducted over nine months and included a health
coaching component. The author served as the facilitator for Cohort I and coordinated various
whole health educational topics presented by interdisciplinary subject matter experts. The
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sessions for Cohort II were conducted over nine weeks, but did not include a health coaching
component. A facilitator coordinated various whole health educational topics presented by
interdisciplinary subject matter experts. The control group, Cohort III, did not include health
coaching, did not use a facilitator, and did not use interdisciplinary subject matter experts to
provide whole health education.
Gantt Chart
The DNP project took place from January 2019 to December 2020. A Gantt chart is
provided to illustrate the project’s milestones (see Appendix F). The author’s original Gantt
chart, developed in the first semester of the DNP program for this QI project, changed after
receiving internal feedback. The original project’s topic was aimed toward the development of a
staff toolkit for future teams to use for launching their own SMAs. After consultation with the
DNP’s chairperson, the author changed the QI project course to include comparing clinical
outcomes from three groups of Veterans. The Gantt chart depicted activities from the start of the
project through completion, to include required coursework needed for graduation. Milestones
included planning, implementation, evaluation, and closeout phases of the project.
Assessment and problem identification. The assessment and problem identification
phase was initiated in February 2019 and included developing the PICOT question and Aim
Statement. The evidence-based literature review regarding the impact of the opioid crisis, SMAs
in clinical settings, and past approaches and modalities was completed in October 2019. It
formed the basis of this change of practice DNP project.
Planning. The planning phase took place from June 2019 through October 2020 and
included retrospective record reviews of 90 participants in three cohorts in this study.
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Additionally, a toolkit for Veteran use during opioid safety SMAs was finalized during this
phase of the project.
Implementation. The implementation phase took place from November 2019 through
July 2020. It included analyzing extracted data, interpreting findings, and formulating
assumptions from data collected from 90 medical records of participants involved in this project.
During this phase, a SharePoint site was created comprised of educational materials and slide
presentations that could be used to conduct opioid safety SMAs locally and at other VA
facilities.
Evaluation. The project evaluation began in August 2020 with data analysis and
synthesis of project findings and submission of the final DNP project concludes December 2020
with the final DNP project presentation.
Work Breakdown Structure
This project involved evaluating the effectiveness of whole health opioid safety SMAs
for Veterans reliant on opioids at the project site. A top-down approach of the work breakdown
structure (WBS) was used to execute the objectives of this change of practice DNP project by
graphically displaying the increments of work into individual steps to ensure all tasks aligned
with the proposed timeline and priorities in the project (see Appendix G). The approach selected
to conduct the WBS was based on the nursing process, including assessment and problem
identification, planning, implementation, and evaluation. The author identified the tasks early
since formulating the four phases of the WBS were continued through to the full implementation
of the project. The WBS fit well into the VA culture and served as an effective means to track
and trend progress from start to completion.
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In preparation for constructing the WBS, a meeting was conducted with the on-site
mentor to determine the project’s scope, implementation, and associated costs. The WBS was
key to the successful completion, launch of interdisciplinary use, and enterprise-wide
dissemination of SMAs for a whole health approach for Veterans to choose sustainable and
effective non-medication alternatives for chronic pain. The potential for sustainable lifestyle
changes for Veterans reliant on opioids for pain management is extremely important and relevant
to our nation, individuals, and communities during this crisis.
Strength, Weaknesses, Opportunities, and Threats (SWOT) Analysis
The interventions in this project were analyzed using a SWOT analysis (see Appendix
H).
Strengths. This program’s identified critical strength was the baseline outcome data
collected by the original SMA team, which revealed promising results. The SMA built
comraderie, a sense of community, and accountability and empowered Veterans to decide how to
manage their pain based on their preferences and goals. An additional strength of this program
included the program’s whole health foundation, where the Veteran oversaw all healthcare
decisions made about him or her, placing them in charge of all healthcare decisions affecting
them.
Weaknesses. The program’s identified weakness was its ability to be spread throughout
other VA facilities, due to primarily the PACT providers’ resistance to change from the
traditional method of delivering opioid safety training during routine in-office appointments.
Additional weaknesses included not all Veterans reliant on chronic opioids in the SMAs due to
work or family constraints and those uncomfortable in group settings.
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Opportunities. Opportunities were identified, such as inviting PACTs who had not yet
integrated opioid reduction strategies to observe SMA sessions while progressing to understand
the potentially improved outcomes from running group appointments. Another opportunity of
this project was in the potential cost savings, as multiple patients could be seen during one SMA.
The opportunity exists for future grant funding to assist with the spread of the opioid safety
program enterprise-wide. An additional opportunity is for the success of this QI project to be
spread to other VA facilities nationwide.
Threats. Identified threats included PACTs deciding to deviate from the specified
training curriculum to educate their patients on opioid safety. Additionally, there was reluctance
from PACT staff to explore what really mattered in their lives with their patients. Other threats
included that Veteran participation in SMAs was voluntary, which may have negatively affected
attendance. Finally, Veterans may be resistant, fearful, physiologically dependent, or not ready to
make whole health changes. Like so many initiatives and programs, a major barrier for spreading
this program was the Coronavirus pandemic that ravished our nation. As of March 2020, the allhands-on-deck philosophy was applied to all healthcare personnel in combating the historical
virus. Due to infection control practices and social distancing requirements, all face-to-face
appointments and group meetings were cancelled until further notice. Mitigation plans have
included working with Veterans to find alternative approaches that would be acceptable and
effective for managing their pain. As a transformational leader, during this pause, the author has
remained passionate and connected with every PACT team and all stakeholders to maintain this
important project’s work. The use of systems thinking helped to overcome uncontrollable
barriers by finding new methods to understand and revise the nature of things, to include how to
intervene to improve population health (Peters, 2014).
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Project Budget
Although hard to quantify, the major return on investment from this DNP project was
assisting Veterans in decreasing their opioid reliance. The budget (see Appendix I) for this
project included the following staff salaries needed to conduct a 90-minute SMA: $154 for the
PC physician, $45 for the RN, $31 for the LPN, $27 for the MSA, and $85 for the pharmacist,
totaling $342 in personnel costs. The full opioid safety SMA program was comprised of nine
sessions, with personnel costs totaling $3,078.
The total budget to complete this project for the first year, comprised of 12 SMAs, was
$9,653, with a projected 2% cost of living increase for the subsequent two years. A one-time,
upfront training requirement to attend the mini-residency to prepare the staff to conduct an SMA
was required at the cost of $5,496, which included $53 for printing educational materials and
plastic binders training materials collected throughout the SMAs.
Although no additional revenue was directly placed back into the budget, in the end,
these healthy behavior changes could eventually impact Veterans’ lives and result in less drain
on the VA healthcare system. Data specific to associated healthcare expenditures related to
opioid reductions were not found in the review of literature. Veterans potential benefits in lifelong, healthy behavior changes, including decreasing their opioid reliance, may far outweigh the
minimal costs associated with conducting a 9-week SMA on opioid safety.
Responsibility/Communication Plan
The communication plan included keeping all stakeholders aware of the project’s
progression from initiation through completion (see Appendix J). To achieve this plan, weekly
meetings with the University of San Francisco (USF) advisor, Dr. Mary Lynne Knighten, via
phone, email, zoom, or text messages, were conducted. Monthly meetings occurred with the
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ELT, director of PC clinics, and fellow team members. Additional weekly meetings were
conducted with the field advisor at the project site. Monthly meetings were conducted with the
lead pharmacist and University of Alabama faculty member, who served as an on-site mentor to
the author through the completion of the project.
Cost-Benefit Analysis
The author’s business plan for implementing an opioid safety SMA program was a costbenefit venture, in that opioid safety education was provided for up to 20 Veterans in a group
setting over 90 minutes at a cost to the organization of $342 per SMA, versus the present option,
where 20 Veterans received opioid safety education via routine office visits at $250 per visit, for
a cost of $5,000. A cumulative annual cost avoidance of $62,424 (for 20 Veterans) will be
realized within three years of program implementation (see Appendix K). The financial analysis
reflected variations in the way we provide opioid safety education to our Veterans and provided
an opportunity to improve future care delivery throughout the VA enterprise.
A cost-benefit analysis for achieving this goal yielded a strong return on investment, with
a projected cumulative 3-year cost-benefit of $51,970.06. Along with the potential 3-year costbenefit, the intangible benefits of implementing an opioid safety SMA program included
providing education in a humane, patient-centered, compassionate manner. The DNP project
aligned with the Birmingham VA Medical Center’s mission to honor Veterans by providing
exceptional healthcare that improves their health and well-being. Additionally, the author’s
financial analysis was directly aligned with DNP Essential II: Clinical Scholarship and
Analytical Methods for Evidenced-Based Practice (American Association of Colleges of
Nursing, 2006).
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In addition to the number of lives lost each year to opioid overdoses, the opioid crisis has
had a significant financial impact on our nation. Current estimates from the CDC reflect an
estimated $78.5 billion a year economic burden from the opioid crisis, which includes healthcare
costs, productivity losses, treatment for addiction, and criminal justice involvement (NIDA,
2019). Results support the SMA whole health conceptual framework model utilizing an
interdisciplinary staff as a cost-effective approach to reduce opioid reliance and improve opioid
safety in a Veteran population.
Study of the Interventions
Continuous Quality Improvement (CQI). The author’s chosen CQI approach used to
assess the impact of the interventions in this project used the four stage, problem solving model
of plan, do, study, act (PDSA; see Appendix L). The use of a PDSA model was chosen as it
provided the author a scientific method to determine if the interventions led to achieving the
projects aim (Institute for Healthcare Improvement, 2016).
This change of practice DNP project required a review of existing clinical practices for
delivering opioid safety education at the project site. Evaluation of clinical data from
retrospective record reviews was conducted to establish whether the outcomes were due to the
interventions. Record reviews, also known a chart reviews, are a frequently used process to
collect retrospective data to answer clinical questions (Sarkar & Seshadri, 2014). To ensure the
accuracy and quality of the extracted data, the author personally completed all record reviews.
The data collection instrument used was a de novo form without established validity or reliability
and has been identified as a valuable lesson learned from this study.
Outcome Measures
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Comparisons were made between the opioid safety outcome measures of those who
received training via Cohort I, comprised of a PACT team that met monthly over nine months
and included health coaching, to Cohort II, comprised of PACT staff that met weekly over nine
weeks and excluded health coaching, to Cohort III (control), who received training via routine,
status quo, in-office education only. The following outcome measures were selected to
accurately represent the phenomenon under study, based on their impact on the safety of the
Veteran population:
1. The MEDD 12 months post-program completion compared to the MEDD pre-SMA.
2. A reduction in the pain score 12 months post-program completion compared to the
pre-SMA score.
3. An increase in CAM usage 12 months post-program completion compared to preSMA usage.
4. A comparison of outcomes and efficacy after 12-month completion of SMA related to
eliminating health coaching from the standard of care used by Cohort II pre-SMA.
To ensure the data collection’s completeness and accuracy, the instrument used for this QI
project was a retrospective record review completed by the author. The author had planned to
collect data from the PROMIS 29 form (see Appendix M) and a de novo Report Cards (see
Appendix N) of SMA participants to assess their well-being and satisfaction; however, a random
review revealed a systems issue in the form collection process. Therefore, all data were collected
from retrospective reviews of computerized records of Veterans who participated in SMAs on
opioid safety. All measures were recorded pre- and post-SMA and in-office visits. Descriptive
statistics described trends in the data. The author obtained input from patients, staff, and
leadership at the project site regarding their perspectives on this DNP project’s chosen measures.
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Before this change of practice DNP project, the author was unable to locate any evidence in the
literature, or at the local level, of satisfaction or cost measures being evaluated related to
decreasing opioid reliance using a whole health approach.
Analysis
The intended outcomes measures for this DNP project were as follows: a reduction in
MEDD and pain scores and an increase in the use of CAMs for the management of pain. Results
of pre- and post-SMA statistical and clinical findings are displayed in Table 1 in Section IV.
The quantitative data regarding MEDD and pain scores were obtained from retrospective
record reviews. The qualitative data regarding the use of CAMs were obtained from retrospective
record reviews. The author performed the retrospective record reviews. The data were collected
using a de novo collection tool (see Appendix O). The author was assisted by an expert in
statistics at the project site in extracting outcome data into an Excel spreadsheet, displayed as
column charts. The data were stratified into three levels of variables, to include comparison
groups of Veterans who have participated in the original team’s opioid safety SMA over nine
months with health coaching, to those who participated in another PACT’s SMA over nine weeks
without health coaching, to those Veterans who received in-office opioid safety education only.
Time was recognized as a variable; in that Cohort I held their SMAs over nine months versus
Cohort II, who held their SMAs over nine weeks. To determine the statistical significance, a p
value of 0.05 was established. To determine clinical significance, a percentage change of
outcome data was calculated pre- and post-SMA.
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Ethical Considerations
On August 20, 2019, the USF DNP department determined that this project met the
guidelines for an evidence-based change of practice project, as outlined in the DNP project
checklist (statement of determination) and was approved as non-research (see Appendix P).
Additionally, a statement of non-research determination was obtained from the VA (see
Appendix Q). Prior to project implementation, the author completed a Human Subject Research
course provided by the Collaborative Institutional Training Initiative. The VA facility leadership
fully supported this project (see Appendix R). Issues with patient privacy concerns and the
protection of participants’ physical and psychological well-being were safeguarded in this
project, as data were obtained via a retrospective record review using the computerized patient
record system. This project complied with the Health Insurance Portability and Accountability
Act, as names and identifiers were not collected, and all data were presented in aggregate form.
No conflicts of interest were identified.
Jesuit Values
This QI project was directly congruent with the USF’s Jesuit values for treating Veterans
with respect and dignity while partnering with them in shared decision-making. In addition, it
aligned with the Jesuit value of Cura Personalis, which means caring for the whole person with
respect to their intellectual, spiritual, and physical health and autonomy (USF, 2019). Jesuit
values and code of ethics values were clearly demonstrated in this project.
ANA Ethical Standards
Notably, Pender’s HPM and the VA’s whole health model, which served as the
foundation for this project, aligned with the Jesuit value of caring for the whole person and the
value of forming and educationg agents of change. Furthermore, in alignment with the American
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Nurses Association’s (2015) Code of Ethics and Interpretive Statements, this project has added
to the nursing profession by advancing scholarly inquiry in the area of health, safety, and wellbeing. Compassion and respect were shown for the participants involved in this study, both
individually and collectively, throughout this project.
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Results
The initial steps of the interventions included randomly assigning study participants into
three cohorts. Modifications to the initial interventions were not needed and remained consistent
throughout this change of practice DNP project. Data were collected before and after patient
participation for each study group. A two-tailed, paired t-test was performed, with a p-value of ≤
0.05 selected to indicate significance. As introduced earlier, clinical significance was calculated
by percentage change pre- and post-SMA results.
Quantitative Findings
The project’s sample size (n = 90) comprised Veterans on chronic opioids receiving care
at the project site. As displayed in Table 1, data analysis revealed the only cohort with a
statistically significant reduction in MEDD was Cohort I (p < 0.0063). Cohort II was the only
one that made a statistically significant improvement in pain scores (p < 0.0202) and CAMs (p =
0.0117). However, in looking at the magnitude of change between the variables pre- and postSMA, patients in all three cohorts made clinically significant improvements in reducing MEDD
and pain scores and increased use of CAMs. These findings demonstrate proof of concept for the
promise of SMAs in managing chronic pain in this population. Clinical improvements for each
variable and cohort are reflected in percentages in Table 1.
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Table 1
Change in Study Variables for Each Cohort
Variable

Cohort I (n = 30)
Cohort II (n = 30)
9-Month with Health 9-Week without
Coaching
Health Coaching

Control (n = 30)
In-Office Only

MEDD

Mean ± SD:
-21.8 ± 15

Mean ± SD:
+0.75 ± 0.53

Mean ± SD:
+0.57 ± 0.4

Clinical Change
21%
Reduction

Clinical Change
2.3%
Reduction

Clinical Change
0.5%
Reduction

p-value:
0.0063

p-value:
0.6371

p-value:
0.8819

Mean ± SD:
-0.4 ± 0.28

Mean ± SD:
+1.13 ± 0.80

Mean ± SD:
-0.6 ± 0.42

Clinical Change:
29%
Reduction

Clinical Change:
46%
Reduction

Clinical Change:
27%
Reduction

p-value:
0.6085

p-value:
0.0202*

p-value:
0.2599

Mean ± SD:
+0.10 ± 0.07

Mean ± SD:
+0.2 ± 0.14

Mean ± SD:
+0.1 ± 0.07

Clinical Change:
23%
Increase

Clinical Change:
20%
Increase

Clinical Change
20%
Increase

p-value:
0.3746

p-value:
0.0117*

p-value:
0.3255

Pain
Score

CAM

*P-value of ≤ 0.05 selected to indicate significance.
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The first major clinical outcome of this change of practice DNP project was that each of the three
cohorts made clinical improvements reducing MEDDs and pain scores and in increasing the use
of CAMs.
Clinically Significant Findings
As compared to the above statistical findings, clinically significant findings of this study
reflect the magnitude of change the intervention made on clinical practice and the quality of life
for Veterans (Ranganathan, Pramesh, & Buyse, 2015). Of the 90 patients, 36 patients made
reductions in their MEDD, 31 patients reported lower pain scores, and 19 patients added a CAM
into their plan of care.
Clinical improvement in MEDD. Of the 30 patients in Cohort I, 13 patients reduced
their MEDD, for a combined reduction of 21%, compared to Cohort II, where 10 patients
reduced their MEDD, for a combined reduction of 2.3%, compared to Cohort III, where 13
patients reduced their MEDD, for combined reduction of 0.5%. The total MEDD percentage
change post -SMA was 2,567.14 milliequivalents, compared to pre-SMA of 3,169.64
milliequivalents, for a combined 21% reduction. Cohort II MEDD post-SMA was 965
milliequivalents, compared to pre-SMA of 987.5 milliequivalents, for a combined reduction of
2.3%. Cohort III (control) MEDD post-SMA was 1457 milliequivalents, compared to pre-SMA
of 141464, for a combined reduction of 0.5%.
Clinical improvement in pain scores. Of the 30 patients in Cohort I, nine patients
reduced their pain scores, for a combined reduction of 29%, compared to Cohort II, where 14
patients reduced their pain scores, for a combined reduction of 46%, compared to Cohort III,
where eight patients reduced their pain scores, for a combined reduction of 27%.
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Clinical Improvement in Use of CAMs. Of the 30 patients in Cohort I, seven patients
increased their use of CAMs, for a combined increase of 23%, compared to Cohort II, where six
patients increased use of CAMs, for a combined increase of 20%, compared to Cohort III, where
six patients increased use of CAMs, for a combined increase of 20%.
The second outcome from this change of practice DNP project was developing a Veteran
toolkit for use during future SMAs. The toolkit was developed based on requests from PACTs
for a consolidated packet of training materials to conduct opioid safety SMAs. The toolkit will
benefit VA providers and clinicians who assist countless Veterans participating in the whole
health opioid safety SMAs, both locally and nationally. The guide directly aligns with the
Veteran Toolkit and will provide a consistent, standardized curriculum to deliver opioid safety
education.
Missing data in this change of practice DNP project include participant demographic data
of age, gender, and race, which have been identified as weaknesses of this study.
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Discussion
Summary
The overarching aim of this DNP project was: By September 2020, 30 Veterans at the
VA project site who participated in a 9-month whole health opioid safety SMA led by PACT
staff to include a health coaching component would have a 10% or greater decrease in the
MEDD and decreased pain scores and a 10% increase in the use of CAMs for pain management,
compared to 30 patients who participated in a 9-week whole health opioid safety SMA led by
PACT staff without health coaching, compared to 30 Veterans who received in-office opioid
safety education. The outcome data from record reviews pre- and post-SMA provided evidence
that the DNP project aim was successfully achieved with two of the three proposed outcomes
within one year of implementation of the program. Based on the outcome data from Cohort I, the
author believes the use of health coaching over nine months conducted in a group setting made
the greatest contribution to project’s success.
The chosen theoretical frameworks selected for use in this change of practice DNP
project provided a firm foundation for building the whole health curriculum, focusing on the
concept of self-efficacy for Veterans decreasing their opioid reliance.
This QI project’s findings reflect that clinical improvements can be achieved when
patients receive opioid safety education, are offered alternatives to manage their pain, receive
health coaching, and set their own SMART goals. A second major outcome was the development
of a Veteran toolkit for use during future SMAs. Although not originally intended, a third major
outcome creating an Implementation Guide for PACT teams to use for launching opioid safety
SMAs in other clinics and facilities. A copy of the Implementation Guide’s index is included in
Appendix S.
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A valuable lesson learned from this project includes the importance of developing a
comprehensive, validated data collection tool prior to conducting record reviews. Such a tool
would have saved the author valuable time and would have added to the credibility of this
project.
Several assumptions can be made from the results of this DNP project. Cohort I achieved
a 21% decrease in MEDD. In part, results may reflect unique contributions of coaching and
interventions of prolonged duration of nine months, compared to nine weeks in Cohort II and III.
Self-efficacy, or the belief in one’s capacity to produce change, plays a critical role in behavior
change and requires behavioral feedback over time (Bandura, 2013). Therefore, Cohort I’s
reported a significant reduction in MEDD outcomes may have been due to its members having
the opportunity to collect behavioral feedback and foster self-efficacy. Provider effects, or
systematic effects of provider, on outcomes beyond treatment modalities, may also have
contributed to observed outcomes (Lutz & Barklam, 2015).
An additional assumption is that Cohort I’s primary goal in implementing SMAs was to
reduce opioid usage, In contrast, Cohort II and III may have emphasized on the use of CAMs to
manage their pain. In analyzing Cohort I’s outcomes, an incidental finding was detected in
participants achieving a statistically significant decrease in their MEDD, without achieving a
statistically significant increase in their pain scores, indicating even though their opioid dose was
decreased, the participants’ pain did not statistically increase. This may be attributable to a
lagged response and may result in future reported pain scores. Additionally, the possibility of a
placebo effect occurring of Veterans believing they were going to improve; therefore, they did
(The Placebo Effect, May 2019).
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Assumptions can be made that patients may have difficulty distinguishing changes in
their pain perception due to the chronicity of pain. A condition known as opioid-induced
hyperalgesia has been found to create a paradoxical response in certain patients on chronic
opioids; whereby, the treatment of pain causes the patient to become more sensitive to painful
stimuli (Lee, Silverman, Hansen, Patel, & Manchikanti, 2011). Additionally, opioid tolerance,
defined by Colvin, Bull, and Hales (2019) as the increased need for analgesia, is a condition that
affects certain patients on chronic opioids, which may explain the lower change in pain scores in
Cohort I and III.
Cohort II’s and Cohort III’s reduction in MEDD may be due to increased monitoring of
provider’s adherence to CDC and VA opioid prescribing guidelines, to include tapering methods
to reduce patient’s chronic opioid usage (Dowell, Haegerich, & Chou, 2016; U.S. Department of
Veterans Affairs, 2017).
Cohort I achieved a 29% reduction in pain scores, compared to Cohort II (46%) and
Cohort III (27%). Cohort II’s and Cohort III’s reductions in pain scores may be due to higher
MEDD trends and increased emphasis on using CAMs to manage their pain. The reductions in
reported pain scores in all three cohorts may be attributable to the team’s focus on increasing the
use of CAMs to control pain. Additional psychological factors of the participants, such as
depression, anxiety, or level of coping skills, have been shown to influence variability in
reporting pain levels (Schneider et al., 2012).
Clinical improvements were observed in pain score and complimentary medicine of
Cohort II and Cohort III participants; however, these findings must be interpreted with caution
due to the higher MEDD trend of both groups. Cohort I achieved a 23% improvement in use of
CAMs, compared to Cohort II and Cohort III, who achieved a 20% increase in CAMs. Cohort I’s
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higher percentage may be due emphasis placed on using CAMs over medication for pain relief.
To determine if access was a variable in patients increasing their use of CAMs, the author met
with the administrative officer in charge of scheduling CAM appointments and determined equal
accessibility to appointments at each cohort location. Additionally, increased usage of CAMs in
Cohort II and Cohort III may have increased promotion by the PACT team. Cohort III’s (control)
method of providing opioid safety training using the status quo mode of delivering in-office
sessions without a whole health set curriculum or health coaching may have contributed to their
lower percent of MEDD reductions. An assumption can be made that Cohort III’s in-office
education was geared toward the provider’s goal of decreasing MEDD, with little input from
their patients on how to proceed with their pain management and whole health goals. An
additional assumption can be made that the 20% increase in the use of CAMs in Cohort III was
attributable to the provider’s efforts and external pressures to address their patients’ pain without
increasing their MEDD.
Upon completion of the program, a new possibility for change occurred. Several
participants expressed their desire to attend ongoing sessions to maintain their momentum and
achieve progress in meeting their SMART goals. In response, and as part of the team’s
sustainability plan, monthly maintenance SMAs have been held for participants to continue their
whole health journey. To familiarize SMA participants and staff with using virtual training
platforms during the pandemic, education was provided by the implementation team and
telehealth staff. Reference sheets with instructions were sent to each participant prior to the SMA
start date. To date, ten virtual opioid safety SMAs have been successfully conducted, with an
average of six Veterans per session.
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Dissemination Plan
As a result of the team earning Gold Fellow Status from the VA Diffusion of Excellence
Shark Tank competition, future dissemination plans of this best practice are to spread the
approach and to sustain the process improvement, to include offering ongoing opioid safety
mini-residency training to VA facilities, both locally and nationally. The team’s latest spread
includes training three PACTs using VA Video Connects virtual platform for a VA facility in the
Northeast United States.
Unanticipated Outcomes.
Although not originally intended, based on requests from interested PACT teams, a major
outcome of the project was creating an Implementation Guide (see Appendix S) for PACT teams
to use for launching opioid safety SMAs in other clinics and facilities. The guide will provide a
consistent, standardized curriculum that will support the patient toolkit.
An outcome from this DNP change of practice project provided the opportunity and
capacity to sustain support for Veteran’s behavior change was based on the request from
participants to attend “alumni” SMAs after they completed of the nine-session program. As of
October 2020, three groups of graduates have continued their whole health journey by attending
monthly SMAs.
An additional opportunity arose during this project for the author to contribute to the
publication of the American Hospitals Association (AHA) Opioid Stewardship Guide. Once fully
launched, the guide, will be distributed to all U.S. hospitals to share best practices regarding
opioid safety and care delivery nationally. The author’s contribution to the guide included
sharing the use of SMAs to help reduce opioid reliance in the Veteran population using a whole
health approach.
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As a result of earning Gold Level Status from the VA Diffusion of Excellence Shark Tank
competition, disseminating this best practice has been spread to three PACTs at the Boston VA.
Future plans include combining data from the Boston VA with that from the author’s project site
to compare and contrast data from a national perspective, to include possible publication.
As the COVID-19 pandemic moves forward, so does the opioid epidemic, as recent data
indicate an 11.4% increase in opioid deaths occurring in January 2020, compared to the same
period in 2019 (Advisory Board, 2020). The current Covid-19 related public health measures,
such as shelter-in-place orders, have caused patients battling with sobriety and addiction to lose
their support networks, resulting in feelings of isolation (Silva & Kelly, 2020). Although
necessary, such public health measures to turn the pandemic’s tide have been linked to poor
mental health outcomes due to repercussions from fear, job loss, and need for social distancing.
(Panchal et al., 2020).
To combat feelings of isolation and anxiety over not being able to connect to their
healthcare team, the whole health opioid safety SMA team at the project site has started a series
of weekly, virtual sessions via the VA’s Video Connect platform. To date, the staff have held 12
SMAs using this virtual platform and have found Veterans receptive and excited about
connecting and seeing their healthcare team on their computer screen. Sessions have included
opioid safety measures, healthy eating, weight gain, body movement, and health coaching, where
discussions have centered on the Veterans current goals, barriers to achieving goals, and potential
options for their healthcare. Feedback to this point has been positive, with the same number of
Veterans returning each week to the sessions. Several Veterans mentioned that they had not left
their house for months and find these weekly sessions something they look forward to. A recent
SMA discussion focused on sleep hygiene presented by a staff psychologist. Conducting virtual
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whole health SMAs to reduce opioid reliance is expanding access to care for Veterans who would
not routinely travel to the VA during this pandemic to receive supportive care. By continuing
virtual SMAs during the pandemic, the team hopes to build trust with their patients and provide a
sense of connectivity during these uncertain times. The team strongly believes this connectivity
has empowered the Veterans to become in charge of their healthcare decisions during these
uncertain times.
As a DNP-prepared leader, the author’s future plans to influence the VA culture and
external healthcare systems to adopt this approach include promoting the ease of program
implementation and sharing the team’s expertise and resources via mini-residency training.
Additionally, the author will continue to present program successes on VA community of
practice calls, reaching approximately 500 PC team members nationwide.
This change of practice DNP project has direct implications for advanced nursing
practice, as it provides an opportunity for nurses to promote whole health opioid safety SMA
programs, which have the potential to change lives, decrease the risk of opioid addiction, and
influence future practice guidelines for addressing our nation’s opioid crisis.
Interpretation
It can be inferred from the results of this DNP project that a one-size-fits-all approach
does not exist for resolving the opioid crisis. However, the evidence from this project supports
using whole health opioid safety SMAs can have a positive clinical effect on decreasing MEDDs
and pain scores and increasing the usage of CAMs for pain management, despite variations in the
approach. Positive results from this project were similar to outcomes from teams who used
SMAs to impact other health conditions, such as diabetes and hypertension (Cain et al., 2017;
Drake et al., 2018; Edelman et al., 2012; Omogbai & Milner, 2018). Results of this study
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indicate that the clinical improvements made by patients in this study and the benefits of
conducting opioid safety SMAs far outweigh the costs.
The results of this change of practice DNP project have direct implications for replication
at other VA healthcare facilities, requiring involvement from both senior nursing executives and
staff development professionals. Future implications for PACTs and staff development personnel
include the ability to access the Veteran Toolkit and Implementation Guide to conduct future
SMAs in their facilities.
Valuable outcomes for this project included Veterans who participated in SMAs with
health coaching demonstrated a statistically significant decrease in their MEDD usage, compared
to Veterans who attended SMAs without health coaching and those who received opioid safety
education delivered in the traditional status quo mode of in-office education. However, at this
time, the author does not have follow-up data and, so cannot speak to the intervention’s
sustainability. Results from Cohort III indicate maintaining the status quo in delivering opioid
safety education did not make a statistically significant difference in impacting MEDDs, pain
scores, or use of CAMs to manage pain; however, clinical improvements in each measure were
achieved. Findings support the HPM and whole health conceptual frameworks used in this DNP
project. The proposed financial estimates for conducting this project were forecasted accurately
and resulted in substantial cost savings for the project site.
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Limitations
The study’s limitations should be acknowledged, including the retrospective data
collection, differences in patient and team composition demographics, and institutional variance
in implementation (9-month versus 9-week) SMAs. Additional limitations include that SMAs
were conducted in a single VA facility and involved only Veterans in group settings, affecting
the study outcomes. The small sample size of reviewed records (n = 90) may not have been
adequate for detecting a statistically significant difference between the three groups of Veterans.
The small number of studies and the study design may have limited the number of conclusions
that could be drawn concerning the evidence-based practice question and aim. Also, Veterans
may have been unable to participate in SMAs due to travel restrictions, travel costs, discomfort
in groups, or mobility issues. Attendance, sex, race, and age demographics for the study
participants were not collected and are identified weaknesses of this project. Reported pain
scores were subjective and easily influenced by numerous objectives, such as time of day and
state of mind. An identified weakness was the inability to collect qualitative findings for wellbeing and satisfaction via valid and reliable instruments (PROMIS 29 and de novo Report Cards)
due to the lack of a standardized approach for collecting the forms. This system issue has been
corrected for teams moving forward.
Identified barriers to the successful implementation of this program included lack of
engagement by Veterans and staff in conducting and attending the weekly sessions. The program
required time commitment and willingness to arrange schedules to participate. Additional
barriers included difficulty in securing meeting space and obtaining protected clinic time to
conduct the SMAs. Finally, an identified barrier for this change of practice DNP project was the
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potential for leadership support to dwindle due to competing priorities, such as staff realignment
during the Covid-19 pandemic.
Strategies to mitigate the noted limitations included the author presenting at various
PACT staff meetings and morning huddles, sharing outcome data, and offering educational and
logistical support for implementing SMAs. Additional future efforts could include leadership
support in offering lunch-and-learn sessions to provide information on the severity of the opioid
crisis impacting the Veteran population. Signage to provide awareness of the opioid crisis was
placed around the project site, including elevator wraps (see Appendix T) and flyers promoting
the importance of whole health modalities (see Appendix U). The COVID-19 pandemic has
stretched the implementation team to find innovative modalities to conduct SMAs via telehealth
platforms in lieu of face-to-face group sessions. The project site did not have locally distinctive
characteristics that impacted the implementation of this DNP project. Although some selection is
bias inherent, the findings of this study suggest benefit from conducting SMAs that incorporate
health coaching over a longer period. Future studies are warranted to support these findings.
Meaningful and logical next steps that could extend and compliment this study include forming
larger cohorts, conducting and collecting SMA data from other VA facilities, and collecting
more extensive data.
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Conclusions
Results of this evidenced-based change of practice DNP project indicate the use of opioid
safety SMAs using a whole health approach is a simplistic, cost-effective, and innovative
approach to addressing a complex problem, the opioid crisis. The most significant result of this
project was establishing an evidence-based, cost-effective approach that can be implemented in
VA and non-VA facilities, which has shown to lead to sustained clinical improvements in
MEDD, pain scores, and use of CAMs for managing pain. Each of the three cohorts in this
project demonstrated clinical improvements, regardless of the approach used. This innovative
program’s primary goal was to fill the existing gap between the status quo of delivering opioid
safety education by implementing SMAs using a whole health approach for managing pain and
saving the priceless lives of thousands of American Veterans. Achieving this goal demonstrated
a decrease in opioid usage and pain scores and an increase in the use of CAMs for managing pain
in a Veteran population.
Spread of this practice has the potential to improve the lives of Veterans with chronic
pain and chronic opioid reliance. Key findings from this project support using the SMA whole
health conceptual framework utilizing an interdisciplinary staff as a mode to reduce opioid
reliance, decrease opioid usage, and improve opioid safety in a Veteran population. The HPM,
paired with the whole health model, provided the framework for this project for Veterans to
identify interventions based on their perceived strengths, self-efficacy, and potential benefits
from making lifestyle changes through creating SMART goals. Further investigation is needed to
investigate this topic of interest.
The intangible benefits of implementing a whole health opioid safety SMA program
include providing education in a humane, patient-centered, compassionate manner. The author
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believes that it is no coincidence that this change of practice DNP project is being completed in
September, during the observance of National Recovery Month. The purpose of this designation
is to educate Americans that with help, those with a substance abuse disorder can live a
rewarding and healthy life and reinforces that behavioral health is essential to overall wellness
(National Association for Alcoholism and Drug Abuse Counselors, n.d.). The opportunity to
answer our nation’s call to defeat the opioid crisis will require a steady hand, strong leadership
support, and a multi-pronged approach using interdisciplinary healthcare staff. The knowledge
obtained through the USF’s DNP-EL program will position the author perfectly to begin to
change the world from here.
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Other Information
Funding
This DNP project did not receive funding from any organization influencing the design,
implementation, interpretation, or reporting of this work.
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Appendix A
Evidence Table

Purpose of
Article or
Review

Design / Method

Sample / Setting

Major Variables
Studied (and their
Definitions)

Measurement of
Major Variables

Data Analysis

Study
Findings

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Betthauser, L. M., Brenner, L. A., Forster, J. E., Hostetter, T. A., Scheider, A. L., & Hernandez, T. D. (2014). A factor analysis and exploration of attitudes and beliefs toward
complementary and conventional medicine in veterans. Medical Care, 52(12), S50- S56. doi:10.1097/MLR.0000000000000219
Purpose:
Design:
Sample: 97
Independent
Measurement of
Data Analysis:
Findings:
Rating:
Study aimed at Qualitative
Veterans
Variable: Veteran
Independent
Three
AcceptLevel III, A/B
exploring
Factor Analysis,
Interviews
Variable:
investigators
ability of
(High/Good Quality)
Veterans
Observational
Setting:
Self-reported via
conducted a
CAMs was
Worth to Practice: Veterans
attitudes and
Study
VA Primary
Dependent
interview
principal factor
associated
believed that complementary
beliefs
Care visits
Variable: Beliefs
analysis with a
with a
modalities involving the mind and
regarding
Methods:
regarding CAM
Measurement of
varimax of 27
history of
body should be incorporated into
complementary Patients
usage
Dependent
items from
PTSD, mild
their care. Finding may assist
alternative
completed
Variable: Extracted
survey.
traumatic
providers in understanding Veterans
modalities
survey,
survey Results
TBI.
willingness to use CAMs.
(CAMs) and
interviews, and
Veterans
Feasibility: CAMs cost-effective
conventional
self-reported
supported
for pain management
medicine.
measures during
use of wide
Strengths: Veterans endorsed a
a single visit
range
wide range of CAM alternatives to
complement manage pain.
Conceptual
ary
Weaknesses: Small sample size, no
Framework:
modalities to conceptual framework noted.
None Noted
manage
Conclusions: Veterans who
pain.
participated in this study were
receptive to the use of
complementary modalities.
Recommendations: Will
incorporate findings into project to
support importance of CAM usage
as alternative for opioid usage to
manage pain.
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Cain, E. K., Gordon, A. N., Mooney, K. D., Aikens, G. B., Robinson, M. H., & Howard, M. E. (2017). Impact of shared medical appointment on hypertension clinical outcomes
and medication adherence in a Veteran’s affairs health care system. Journal of Pharmacy Technology, 33(5), 177-182. doi:10.1177/8755122517714578
Purpose: This
purpose of this
QI study was
to determine if
pharmacist- led
SMAs could
improve access
and quality of
care by
impacting
specific
measures in
Veterans with
hypertension

Design:
Quality
Improvement
Study
Methods:
Participants
were on a
minimum of two
hypertension
medications, had
a systolic blood
pressure (SBP)
of >140 mm Hg
or diastolic blood
pressure (DBP)
of > 90

Sample: 21
Veterans

Independent
Variable: SMAs

Setting:
Veterans who
received care at
two VA Primary
Care clinics

Dependent
Variable:
Positive effect on
clinical reductions in
hypertensive
Veterans

Conceptual
Framework:
None

Major Variables
Studied (and their
Definitions)
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Measurement of
Major Variables

Data Analysis

Study
Findings

Measurement of
Independent
Variable
Measurement:
Veterans who
attended minimum of
2-Pharmacist-led
SMAs
Measurement of
Dependent
Variable:
SBP reduction of
76.2% of participants

Analysis:
Baseline
comparison
data was
collected by
two pharmacists
and four
Primary Care
physicians who
compared postSMA
intervention
using
McNemar’s
exact test for
matched pairs,
differences in
mean scores
were evaluated
using a paired,
2-tailed t test

Findings:
Proportion
of Veterans
with
controlled
BP increased
compared to
baseline
readings
from 14.3%
to 42.9%;
SBP
decreased
for 76.2% of
pts.
DBP
decreased
for 52.4%
of pts.

Rating:
Level III, A/B
(High/Good Quality)
Worth to Practice: SMAs growing
in popularity in PC settings
Feasibility: SMAs cost-effective
approach for impacting clinical
results (HPN)
Strengths: Utilized interdisciplinary team to conduct SMAs,
Strong QI study, easily reproducible
in like settings
Weaknesses: Study points out that
a Gold Standard for conducting
SMAs is lacking
Conclusions: Veteran diagnoses,
suggests strong linkage between
strength of education in group
settings over individual office
appointment education.
Recommendations: Study findings
will be incorporated into DNP
project to support the use of SMAs
to impact clinical outcomes using an
interdisciplinary approach
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Major Variables
Studied (and their
Definitions)
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Measurement of
Major Variables

Data Analysis

Study
Findings

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Chen Y., Shiels, M. S., Thomas, D., Freedman, N. D., & Berrington, A. (2018). Premature mortality from drug overdoses: A comparative analysis of 13 organization for economic
co-operation and development member countries with high-quality death certificate data, 2001 to 2015. Annals of Internal Medicine. Advance online publication.
doi:10.7326/M18-2415
Purpose: To
Design:
Sample: Data
Independent
Measurement of
Analysis:
Findings:
Rating:
compare trends Integrative
from 13
Variable:
Independent
Data was
U.S.
Level V, A
in premature
Review
countries was
Premature death rates Variable:
extracted by
mortality
(High Quality)
death rates due
extracted for the
due to drug overdoses Data from 13
four authors of
rate due to
Worth to Practice: Study findings
to drug
Conceptual
study
countries analyzed
the study
opioid
support the need for an immediate
overdoses in
Framework:
Dependent
between 2001
overdoses
solution to address the opioid crisis
13 countries
None Noted
Setting: Not
Variable:
Measurement of
and 2015 and
was twice
Feasibility: Study supports use in
including the
indicated
Data from 13
Dependent
included year,
that of other
project depicting severity of opioid
U.S.
Methods:
countries
Variable:
country, age,
countries
crisis
.
Researchers used
Data extraction
and gender
involved in
Strengths: Used large, international
the World Health
using Stata
this study.
sample from 13 countries
Organ-ization
software
These
Weaknesses: Study failed to
Mortality
findings can compare impact of specific drugs
Database
be directly
effecting death rates by country
to extract the
linked to the Conclusions: The alarming
annual number
three waves
statistics point to the urgent need to
of deaths by a
of the U.S
find a solution for resolving the
drug overdose
opioid crisis opioid crisis
Recommendations: Statistics
provided in this study will be used
to support project and provide an
impetus for a solution to positively
impact the alarming death rates due
to drug overdoses in the U.S.
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Purpose of
Article or
Review

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Christie, C., Baker, C., Cooper, R., Kennedy, P. J., Madras, B., & Bondi, P. (2017). The president’s commission on combating drug addiction and the opioid crisis. Retrieved from:
https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Final_Report_Draft_11-1-2017.pdf
Purpose: To
develop
recommendations to
combat the
opioid crisis to
include a
national
curriculum to
educate
prescribers on
the standards
of care for
administering
opioids

Design / Method

Sample / Setting

Design:
Consensus
Panel/Position
Statement by
Government
Agency

Sample: N/A

Methods: Gov.
Christie led a
Commission to
assist the
President of the
U.S.
Conceptual
Framework:
None

Setting:
Washington, DC

Major Variables
Studied (and their
Definitions)
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Independent
Variable: Opioid
Crisis
Dependent
Variable:
Recommendations
from panel experts

Measurement of
Major Variables

Measurement of
Independent
Variable:
National statistics
Measurement of
Dependent
Variable:
Recommendations to
be shared nationally

Data Analysis

Study
Findings

Analysis:
Report
presented
verbally to the
President of the
U.S.

Findings:
Mental
Health
services are
lacking in
the U.S. as
only 10.6%
of both
youth and
adults who
need
treatment for
opioid
addiction,
receive it.

Rating:
Level IV, A/B
(High/Good) Quality
Worth to Practice: The numerous
recommendations to include
increased media coverage via an
opioid awareness campaign, data
sharing, mental health services,
state-based drug monitoring
programs may inform clinicians and
national leaders of the severity of
the opioid crisis
Feasibility: Actions and
recommendations from the expert
panel support need for immediate
action in resolving opioid crisis and
supports project
Strengths: Panel comprised of
subject matter experts
Weaknesses: None noted
Conclusions: A multi-pronged
approach is needed to address the
opioid crisis facing the U.S.
Recommendations: Data and
recommendations from this expert
panel will be integrated into this
project
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Purpose of
Article or
Review

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Drake, C., Meade, C., Hull, S. K., Price, A., Snyderman, R. (2018). Integration of personalized health planning and shared medical appointments for patients with type 2 diabetes
mellitus. Southern Medical Journal, 111(11), 674-682. doi:10.14423/smj.0000000000000892
Purpose:
Study reviews
the feasibility
of incorporating
personalized
health planning
(PHP) into
SMAs for
patients with
diabetes
mellitus (DM).

Design / Method

Sample / Setting

Design:
Quasiexperimental
study

Sample:
12 patients
attended SMAs

Methods: Pts
randomized to
the PHP SMA
(intervention)
standard SMA
(control).
Conceptual
Framework:
None Noted

Setting: The
Duke Family
Medicine Center

Major Variables
Studied (and their
Definitions)
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Independent
Variable: SMA for
DM patients

Dependent
Variable: Usefulness
of PHP into SMAs

Measurement of
Major Variables

Data Analysis

Study
Findings

Measurement of
Independent
Variable: Evaluation
of feasibility and
implementation

Analysis:
Two coders
used
Consolidated
Framework for
Implementation Research
(CFIR) to
organize data

Findings:
Clinical
outcomes
included
reductions in
hemoglobin
A1c, low
density
lipoproteins,
BMI, and
blood
pressure.
Achievemen
t of health
goals also
obtainable
through use
of PHP
during
SMAs.

Measurement of
Dependent
Variable: Data
extraction

Rating:
Level II, A/B
(High/Good) Quality
Worth to Practice: Use of the
PHP’s in SMAs can assist clinical
teams in impacting DM related
outcomes
Feasibility: Cost-effective approach
to achieve clinical outcomes
supports whole health approach
conceptual framework of project
Strengths: Results of incorporating
PHP into SMA would be a simple
process to replicate
Weaknesses: Small sample size
Recommendations: Findings will
be used in project to support use of
PHPs in SMAs project to impact
clinical
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Purpose: To
assess the
effective-ness
of SMAs on
staff, patient,
and economic
outcomes to
determine if
the impact
differed
between
clinical
conditions, or
specific interventions used

Design:
Systematic
Review of RCTs.
Non-randomized
clustercontrolled trials,
controlled
before-and-after
studies,
interrupted timeseries designs

Sample:
19 RCTs and
Observational
Studies

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Edelman, D., McDuffie, J. R., Oddone, E., Gierisch, J. M., Nagi, A., & Williams, J. W., Jr. (2012). Shared medical appointments for chronic medical conditions: A systematic
review. (VAESP Project 09-010). Washington, DC: Department of Veterans Affairs

Methods:
Observational
Conceptual
Framework:
None Noted

Setting: VA
Primary Care
clinics

Major Variables
Studied (and their
Definitions)
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Independent
Variable: SMAs

Dependent
Variable: Veteran,
staff, and economic
outcomes

Measurement of
Major Variables

Measurement of
Independent
Variable:
Record reviews
Measurement of
Dependent
Variable: Data
extraction

Data Analysis

Analysis:
Electronic
analysis of
results along
with manual
search of
citations

Study
Findings

Findings:
SMAs may
be most
effective for
medical
conditions
that have a
high-risk of
complication
s, such as
diabetes
mellitus
where medication
management and
titration are
important

Rating:
Level II A/B
(High/Good)
Quality
Worth to Practice: SMAs can
positively affect clinical outcomes
such as DM
Feasibility: SMAs are effective in
positively impacting clinical and
economic outcomes, satisfaction of
participants and staff
Strengths: Large sample size of
RCTs
Weaknesses: None noted
Conclusions: Reviews showed that
using SMAs in small, closed
groups, providing breakouts for
medication management improved
outcomes for Type 2 diabetes to
include reductions in HBG A1C,
systolic blood pressure
Recommendations:
Study findings will be incorporated
into project to support the use of
SMAs to impact clinical outcomes
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Purpose:
To evaluate
rates and
correlates
NPMs
use in Veterans
during recent
conflicts

Design:
Qualitative with
Meta- Synthesis

Sample:
Survey results
from 460
Veterans with
chronic pain
defined as lasting
> 3 months

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Edmond, S. N., Becker, W. C., Driscoll, M. A., Decker, S. E., Higgins, D. M., Mattocks, K. M., & Haskell, S. G. (2018). Use of non-pharmacological pain treatment modalities
among veterans with chronic pain: results from a cross-sectional survey. Journal of General Internal Medicine, 33(1), 54-60. doi:10.1007/s11606-018-4322-0

Methods:
Data collected
through record
reviews and
interviews
Conceptual
Framework:
None Noted

Setting: VA
Primary Care
clinics

Major Variables
Studied (and their
Definitions)

72

Independent
Variable: Surveys
Dependent
Variable:
Effectiveness of
alternative NPMs to
manage clinical
outcomes

Measurement of
Major Variables

Measurement of
Independent
Variable:
Record reviews
Measurement of
Dependent
Variable:
Self-reported survey
results

Data Analysis

Analysis:
Using
regression
analysis,
calculated
descriptive
statistics to
examine
bivariate and
multi-variable
associations

Study
Findings

Findings:
Over 12month
period,
approximatel
y 43.7% of
male
Veterans and
56.3% of
female
Veterans in
the study
reported
using a
minimum of
one NPM
within the
past 12
months

Rating: Level II A/B
(High/Good Quality)
Worth to Practice: NPMs can be
alternative to opioid usage
Feasibility: NPMs are a costeffective, safe alternative for
managing clinical outcomes
Strengths: Moderate sample size,
including adequate sample of
female Veterans
Weaknesses: Limited by crosssectional design
Conclusions: Further studies are
needed to determine which NPM’s
are most effective in of care for
various groups of Veterans, specific
to disease condition, and treatment
preferences.
Recommendations: Findings
support project in use of NPMs as
alternative to using opioids for
managing pain
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Conceptual
Framework

Major Variables
Studied (and their
Definitions)

73

Measurement of
Major Variables

Data Analysis

Study
Findings

Level of Evidence (Critical
Appraisal Score) /
Worth to Practice /
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /

Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, J., Hoffecker, L., … Krebs, E. E. (2017). Patient outcomes in
dose reduction or discontinuation of long-term opioid therapy. Annals of Internal Medicine, 167(3), 181. doi:10.7326/m17-0598
Purpose:
Review
completed to
synthesize the
effective-ness
of methods to
decrease long
term opioid
therapy
(LTOT)

Design:
Systematic
Review with
RCTs with MetaAnalysis

Methods: Data
collected through
data extraction

Conceptual
Framework:
None Noted

Sample: Two
investigators
reviewed
abstracts of 67
studies (11 RCTs
and 56
observational
studies)
Setting: None
Noted

Independent
Variable: Record
Reviews

Measurement of
Independent
Variable: 67 studies

Dependent
Variable: Alternative
methods to decrease
LTOT

Measurement of
Dependent
Variable: Data
extraction

Analysis:
Two reviewers
extracted data
to assess quality
of data using
the U.S.
Preventive
Services Task
Force quality
rating criteria

Findings:
Review of
eight
interventions
categories,
including
interdisciplinary
pain
programs,
buprenorphin
e assisted
dose
reductions,
and
behavioral
interventions,
were found
Many
studies
reported dose
reductions,
but rates of
opioid
discontinuation varied
widely

Rating:
Level II A/B
(High/Good) Quality
Worth to Practice: Value in
providers discussing benefits of
tapering LTOT and referring to
interdisciplinary pain teams
Feasibility: Cost-effective means to
findi alternatives for managing pain
Strengths: Study quality was good
for three studies, fair for 13 studies
Weaknesses: Heterogeneous
interventions and outcome measures
Conclusions: Evidence suggests
that numerous interventions may
reduce LTOY. Pain, function and
the quality of life may improve
when opioid doses are reduced
Recommendations: Findings will
be included in the project as
evidence to support the use of
various interventions as effective
alternatives for LTOT
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Purpose of
Article or
Review

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones C. M. (2017). Prescriptive opioid use, misuse, and use disorders in U.S. adults. Annals of Internal Medicine,
167(5), 1-24. doi:10.7326/P17-9042
Purpose:
Determine the
rate of
prescription
opioid misuse,
use, use
disorders, and
motivation for
use by U.S.
adults.
for use was
examined

Design / Method

Sample / Setting

Design:
Qualitative

Sample: 51,200
adults

Methods:
Surveys

Setting: 2015
Survey on Drug
Use and Health
(NSDUH)
conducted in pts.
homes

Conceptual
Framework:
None

Major Variables
Studied (and their
Definitions)

74

Independent
Variable: Surveys

Dependent
Variable:
National rates of
opioid use, misuse,
and motivation for
use

Measurement of
Major Variables

Data Analysis

Study
Findings

Measurement of
Independent
Variable: In-person
interviews

Analysis:
SUDAAN
software (RT)
International
(24) to account
for the complex
sample weights
and design of
the survey

Findings:
Weighted
NSDUH
results
estimated 91.8
million
(37.8%) of
U.S adults
used
prescription
opioids, 11.5
million
(4.7%)
misused
opioids, and
1.9 million
(0.8%) had an
opioid use
disorder.
12.5% of
adults that
were
prescribed
opioids
reported
misusing
them, of
these, 16.7%
reported
having an

Measurement of
Dependent
Variable: Data
extraction

Rating:
Level III A/B
(High/Good)
Quality
Worth to Practice: Prescribers can
gain increased understanding of
opioid use, misuse, and reasons for
usage
Feasibility: Study findings support
urgency to find a solutionfor the
opioid crisis and supports project
Strengths: Large sample size
Weaknesses: NSDUH excluded
homeless person not living in a
shelter, institutionalized residents,
or active-duty military personnel
Conclusions: 2015 survey data
revealed more than one-third of U.S
adults reported using opioids.
Reduction from pain was the key
motivator for using opioids. The
results indicate the need for
expanding access to evidencedbased pain management programs
and to provide ongoing education
on the use of these addictive and
powerful medications
Recommendations: Results will be
integrated into the project as
evidence to support of the severity
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Purpose of
Article or
Review

Design / Method
Conceptual
Framework

Sample / Setting

Major Variables
Studied (and their
Definitions)

75

Measurement of
Major Variables

Data Analysis

Study
Findings

opioid use
disorder. The
most
common
finding for
motivation to
use opioids
was for relief
of physical
pain (63.4%)

Level of Evidence (Critical
Appraisal Score) /
Worth to Practice /
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
of the opioid crisis and the urgency
to find a solution
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Purpose: To
provide
national
prevalence
estimates of
U.S. Veterans
who reported
severe pain
levels and
compares pain
levels of nonVeterans of
similar sex and
age

Design:
Qualitative
Methods:
Data collection
from National
Health Interview
Survey
(NHIS)

Sample: Data
was extracted
from the 2010 2014 NHIS of
67,696 adults
who completed
the Adult
Functioning
Survey
Setting: VA
Primary Care
clinics

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Nahin, R. L. (2017). Severe pain in veterans: The effect of age and sex, and comparisons with the general population. Journal of Pain, 18(3), 247-254
doi:10.1016/jpain.2016.10.021

Conceptual
Framework:
None

Major Variables
Studied (and their
Definitions)
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Independent
Variable: Defined as
a Veteran by either
currently serving in
the U.S. military or
having had served.
Veteran reporting
severe pain
Dependent
Variable: Selfreported assessment
of pain over the past
three months

Measurement of
Major Variables

Data Analysis

Study
Findings

Measurement of
Independent
Variable:
Participants were
identified as having
severe pain via the
imbedded coding
system in the Adult
Functioning and
Disability
Supplement
Measurement of
Dependent
Variable: The
Washington Group
on Disability
Statistics developed
and validated
questions through
pilot surveys and
cognitive testing

Analysis:
X2 test used to
assess the
global
associations
between
categorical
variables and
prevalence of
pain.
Contingency
tables were
used to assess
the relationship
between ordinal
pain and all
other
categories.

Findings:
65.5% of
military
Veterans
reported pain
in the
previous
three months,
with 9.1%
reporting
severe pain,
as compared
to pain
reported from
non-Veterans
of 56.4%, and
severe pain at
6.4%.

Rating: Level III A/B
(High/Good) Quality
Worth to Practice: Study points to
the need for increased attention
needed toward recognition and
treatment of greater severe pain in
the Veteran population
Feasibility: Provides awareness of
severity of pain in Veteran pop.
Strengths: Large sample size, first
study to compare severity of pain
between U.S. military Veterans and
non-Veterans
Weaknesses: Cross-sectional data
unable to prospectively
Determine clinical outcomes, NHIS
unable to retrieve information
regarding pain treatment
Conclusions: Prevalence of pain in
Veterans compared to non-Veterans
is alarmingly higher and must be
addressed using evidenced-based
modalities. The study recommends
revised pain management strategies
be offered to the Veteran population
Recommendations: Study findings
can be integrated into the project to
support solution for managing
severe pain in the Veteran
population
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Purpose of
Article or
Review

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Omogbai, T., & Milner, K. A. (2018). Implementation and evaluation of shared medical appointments in patients with diabetes: A quality improvement study. Journal of Nursing
Administration, 48(3), 154-159. doi:10.1097/NNA.0000000000000590
Purpose: To
implement and
evaluate the
clinical
outcomes and
satisfaction of
Veterans with
diabetes
mellitus who
attended SMAs

Design / Method

Sample / Setting

Design:
Quality
Improvement

Sample: 30 male
Veterans with
DM who
attended SMAs

Methods:
Record Reviews
Conceptual
Framework:
The Chronic
Care Model
(CCM) provided
the framework
for this QI study.
The CCM is
designed to
manage chronic
diseases more
efficiently and
effectively

Setting: VA
Primary Care
clinics

Major Variables
Studied (and their
Definitions)
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Independent
Variable: SMAs
Dependent
Variable: Clinical
outcomes and
satisfaction related to
attending DM-SMAs

Measurement of
Major Variables

Measurement of
Independent
Variable: Record
Reviews
Measurement of
Dependent
Variable: Clinical
outcome data and
satisfaction survey
results

Data Analysis

Study
Findings

Analysis:
Data analyzed
using SPSS
version 23,
descriptive
statistics used to
describe
baseline and
clinical
outcomes data.
Paired t
tests used to
compare
baseline, three
months, and
three to six
months of data

Record
reviews of
Veterans who
participated
in the DM
SMA include
significant
reductions in
A1c,
triglycerides,
total
cholesterol,
and systolic
blood
pressure
when
measured six
months after
the intervention
Veterans satisfaction
scores
increased
significantly
from 22.3
(SD, 2.59) to
35.4 (SD,
0.77)

Rating:
Level V, A
(High Quality)
Worth to Practice: SMAs can
positively impact specific clinical
outcomes
Feasibility: Cost-effective means to
assess impact of SMAs on clinical
outcomes
Strengths: Study guided by strong
conceptual framework
Weaknesses: Certain Veterans
voiced reluctance to discussing
health status during SMA; small
sample size
Conclusions: Results of this QI
study indicates that SMAs can be an
effective modality to influence
clinical outcomes and satisfaction in
Veteran patients with DM.
Recommendations include
spreading the use of SMAs VAwide for all Veterans with DM
Recommendations: Results will be
integrated into project as evidence
to support use of SMAs to impact
clinical outcomes and improve
participant satisfaction
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Purpose:
Review of
mind-body
practices by
Veterans and
active duty
personnel to
determine gaps
in the literature
and to provide
recommendatio
ns for future
research
recommendations

Design:
Systematic
Scoping Review
with MetaAnalysis

Sample: 89
interventions of
active duty
military
personnel
practicing mindbody
interventions

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Rani, E. A., Johnston, J. M., Bormann, J. E., Hull, A., & Taylor, S. L. (2014). A systematic scoping review of complementary and alternative medicine mind and body practices to
improve health of veterans and military personnel. Medical Care, 52(12), 1-15. doi:10.1097/MLR.0000000000000228

Methods: One
reviewer search
five databases
Conceptual
Framework:
None noted

Setting: None
stated

Major Variables
Studied (and their
Definitions)
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Independent
Variable: 2011
National VA survey
Dependent
Variable: Use of
mind-body practices
in a Veteran
population

Measurement of
Major Variables

Measurement of
Independent
Variable: Data
extraction
Measurement of
Dependent
Variable: Article
reviews for inclusion
on mind-body
interventions used in
Veteran population

Data Analysis

Analysis:
PRISMA
checklist was
used to
determine
inclusion
criteria

Study
Findings

Findings:
Interventions
between
1976-2014
to assess 65
health and
wellbeing
outcomes;
most
practices
were
meditation
(n=25),
relaxation
exercises
with imagery
(n=20), PT
and spinal
manipulation
(n=16), and
acupuncture
(n=11)

Rating: Level III A/B
(High/Good Quality)
Worth to Practice: Beneficial in
the primary care setting when
planning approaches for future
development of robust Veteran pain
management plans of care
Feasibility: Veterans open to mindbody interventions for managing
pain
Strengths: First systematic scoping
review that reviewed all mind-body
interventions specific to Veterans
Weaknesses: Only articles
published in English were included
due to limited translation abilities;
search strategy may have failed to
identify all appropriate articles for
inclusion in review
Conclusions: Most prevalent mindbody practices used by Veterans and
military personnel were meditation
and acupuncture. Further research is
indicated for use of Yoga in the
Veteran population
Recommendations: Review of
predominant mind-body
interventions will be integrated into
project to support use of mind-body
modalities to manage Veterans pain
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Purpose of
Article or
Review

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Romanelli, R. J., Dolginsky, M., Byakina, Y., Bronstein, D., & Wilson, S. (2017). A shared medical appointment on the benefits and risks of opioids is associated with improved
patient confidence in managing chronic pain. Journal of Patient Experience, 4(3), 144-151. doi:10.1177/2374373517706837
Purpose: To
evaluate the
confidence
levels of
Veterans who
attended an
opioid shared
medical
appointment
(SMA) on the
treatment of
chronic pain

Design / Method

Sample / Setting

Design:
Prospective
Study

Sample: 130

Methods:
Participants
handed an
anonymous
survey pre-post
SMA
Conceptual
Framework:
None noted

Setting:
Ambulatory
clinic within a
health care
system

Major Variables
Studied (and their
Definitions)
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Independent
Variable: SMAs
Dependent
Variable:
Confidence levels for
managing pain

Measurement of
Major Variables

Measurement of
Independent
Variable: Survey
responses
Measurement of
Dependent
Variable: Data
extraction

Data Analysis

Study
Findings

Analysis:
Logistical
regression
models were
used to explore
differences in
responses by
baseline
characteristics
Descriptive
statistics used to
calculate
responses

Findings:
Chronic pain
who attended
SMAs on
risks and
benefits with
opioid usage
reported
improvements in
confidence in
managing
their pain,
along with
their
healthcare
team’s ability
to manage
pain

Rating:
Level III A/B
(High/Good) Quality
Worth to Practice: SMAs can be
an effective approach for improving
patient confidence in managing pain
Feasibility: Increased confidence to
manage pain supports self-efficacy
and whole health conceptual
framework of prohject
Strengths: Easy to replicate, costeffective, evidence-based
Weaknesses: Study reviewed short
term outcomes only, without a
control group
Conclusions: Patients demonstrated
increased confidence in their ability
and their healthcare team’s ability to
manage pain increased through the
use of SMAs.
Recommendations: Results will be
integrated into project to support
importance of understanding
Veterans confidence levels-selfefficacy in managing pain
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Purpose of
Article or
Review

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Tyndale, R. F., & Sellers, E. M. (2018). Opioids: The painful public health reality. Clinical Pharmacology and Therapeutics, 103(6), 924-935. doi:10.1002/cpt.1074
Purpose: To
discuss the
profound
consequences
of the opioid
crisis, pharmacologic
aspects, public
health policy
and initiatives,
research and
treatment
advances in
both the U.S
and other
countries

Design / Method

Sample / Setting

Design:
Opinion of
nationally
recognized
expert(s) based
on experiential
evidence

Sample: N/A

Methods: N/A
Conceptual
Framework:
N/A

Major Variables
Studied (and their
Definitions)
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Measurement of
Major Variables

Independent
Variable: N/A

Measurement of
Independent
Variable: N/A

Dependent
Variable: N/A

Measurement of
Dependent
Variable: N/A

Setting: N/A

Data Analysis

Analysis:
N/A

Study
Findings

Findings:
Data
provided
regarding
prescription
opioid sales
in U.S.
quadrupled
from 1999 to
2014, without
a significant
change in the
amount of
pain reported
by
Americans.
The U.S. is
the leading
nation for
opioid
prescribing.
This rise in
opioid-related
overdose
deaths can be
attributed to
three separate
waves of
lethal drugs:
first wave of

Rating:
Level V A (Good Quality)
Worth to Practice: Expert opinions
regarding the urgent need for more
funding to find an evidenced-based
solution to the opioid crisis. A
whole health opioid safety SMA can
be part of the solution
Feasibility: N/A
Strengths: Provides history of
opioid crisis in the U.S. and current
severity
Weaknesses: Expert opinions
limited to two authors; systematic
reviews of rigorous studies needed
to make change
Conclusions: Public health crisis of
opioid addiction and death rates will
require additional scientific
leadership and funding to make
needed changes, to include a
national summit to create research
agenda
Recommendations: Much of the
data needed to make change will
require research from federal and
agencies and foundations
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Purpose of
Article or
Review

Design / Method
Conceptual
Framework

Sample / Setting

Major Variables
Studied (and their
Definitions)

81

Measurement of
Major Variables

Data Analysis

Study
Findings

opioid
mortality
deaths began
in the late
1990s
followed by a
second wave
of deaths
from heroin
starting in
2010. The
third wave
has been
occurring due
to synthetic
opioids

Level of Evidence (Critical
Appraisal Score) /
Worth to Practice /
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
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Purpose of
Article or
Review

Design / Method

Sample / Setting

Purpose:
The use of
SMAs in
primary care
settings are
increasing;
however, a
standardized
implementation approach
is lacking

Design:
Systematic
review without
meta-analysis
Methods:
Systematic
review of
qualitative,
quantitative,
mixed method
studies without
meta-analysis.
Categorization of
the extracted
data informed a
thematic
synthesis

Sample: 13
quantitative
controlled trial,
11 qualitative
papers, two
mixed methods
studies

Level of Evidence (Critical
Appraisal Score) /
Conceptual
Worth to Practice /
Framework
Strengths and Weaknesses /
Feasibility /
Conclusion(s) /
Recommendation(s) /
Wadsworth, K. H., Archibald, T. G., Payne, A. E., Cleary, A. K., Haney, B. L., & Hoverman, A. S. (2019). Shared medical appointments and patient-centered experience: A mixed
methods systematic review. BMC Family Practice, 20(1), 97. doi:10.1186/s12875-019-0972-1

Conceptual
Framework:
None Noted

Setting:
Two researchers
extracted data
in library setting

Major Variables
Studied (and their
Definitions)
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Independent
Variable: SMAs

Dependent
Variable:
Standardized
approach to conduct
SMAs

Measurement of
Major Variables

Measurement of
Independent
Variable: Review of
previous studies
Measurement of
Dependent
Variable: Data
Extraction

Data Analysis

Analysis:
To evaluate
qualitative
studies, team
used
Trustworthiness of
Qualitative
Inquiry and
ENTREQ
PRISMA
frameworks

Study
Findings

Findings:
Positive
impact from
SMAs
included
improved
patient
satisfaction,
increase in
feeling
connected
with clinical
team,
resiliency,
and
improved
care
coordination
Review of
past SMAs
demonstrate
lack of a
Gold
Standard for
conducting
them

Rating:
Level III A/B
(High/Good) Quality
Worth to Practice: Primary Care
setting is most appropriate setting to
conduct SMAs; improved resilience
and enhanced coping skills are
important outcomes of SMAs
Feasibility: SMAs are costeffective delivery modality to
improve clinical outcomes
Strengths: Current review updates
the evidence to support the use of
SMAs and enhance patientexperience
Weaknesses: Small number of
studies limited by inclusion criteria,
single-center facilities may limit
generalizability
Conclusions: Standardized training
and implementation of SMA’s is
needed to ensure the most impactful
outcomes.
Recommendations: Results will be
integrated into project to support
importance of developing a
standardized approach for a SMA
curriculum on opioid safety
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Appendix B
VA Proactive Health and Well-Being Model

Note: The Circle of Health is a visual picture of the Whole Health approach to care. This helps
you explore connections between important aspects of your life and your health and well-being.
(Simmons, Drake, Gaudet, & Snyderman, 2016).
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Appendix C
Team Composition Table
Team I

Team II

Who was
involved?

Full PACT Staff

Full PACT Staff

Setting

Shared Medical Appointment

Shared Medical Appointment

Yes

No

No

Handouts, Audiovisual, Classroom Instruction

Verbal

90 minutes every week for 9 Weeks

30 mins-1
Hour

Health Coaching
Utilized?
Education
Delivery
Time Frame

Handouts, Audiovisual, Classroom Instruction
with Coaching
90 minutes every week for 9 Weeks to include
health coaching (60 min.) starting Week 3
Structured around the Whole Health Wheel
Session 1: Introduction to Whole health &
Opioid Safety
Session 2: Working the Body
Opioid Safety: Overdose Prevention
(Naloxone)
Session 3: Surroundings
Opioid Safety: Taking Opioids Responsibly
Coaching Session
Session 4: Personal Development
Opioid Safety: Side Effects & Risk
Coaching Session
Session 5: Food & Drink
Opioid Safety: Pain Care Plan
Coaching Session

Curriculum
Session 6: Recharge & Sleep
Opioid Safety: Withdrawal, Dependence,
Disorder
Coaching Session
Session 7: Relationships
Opioid Safety: Alternatives
Coaching Session
Session 8: Spirit & Soul
Opioid Safety: Opioid Tapering
Coaching Session

Structured around the Whole Health
Wheel
Session 1: Introduction to Whole health &
Opioid Safety
Session 2: Working the Body
Opioid Safety: Overdose Prevention
(Naloxone)
Session 3: Surroundings
Opioid Safety: Taking Opioids Responsibly
Session 4: Personal Development
Opioid Safety: Side Effects & Risk
Session 5: Food & Drink
Opioid Safety: Pain Care Plan
Session 6: Recharge & Sleep
Opioid Safety: Withdrawal, Dependence,
Disorder
Session 7: Relationships
Opioid Safety: Alternatives
Session 8: Spirit & Soul
Opioid Safety: Opioid Tapering
Session 9: Power of the Mind Relaxing &
Healing
Opioid Safety: Storage & Disposal
Session 10: Full Circle Review

Session 9: Power of the Mind Relaxing &
Healing
Opioid Safety: Storage & Disposal
Coaching Session
Session 10: Full Circle Review

Team III
Provider
only
Office
Visit

Not
Structured
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Appendix D
Toolkit Index
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Appendix E
Gap Analysis
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Appendix F
Gantt Chart
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Appendix G
Work Breakdown Structure
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Appendix H
SWOT Analysis
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Appendix I
Project Budget: Costs Associated with 90-Minute, Nine Session SMA
Retroactive Chart Review By RN

$3,375.00

90 pts = 30 min
Printing Paper (2)

$8.00

Plastic Binders (15)

$45.00

Primary Care Physician

$3,510.00

RN

$1,350.00

LPN

$864.00

MSA

$792.00

PharmD

$2,196.00

Dietician

$1,242.00

Revenue

$0.00

TOTAL COST:

$13,382.00
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Appendix J
Responsibility / Communication Matrix
Communication
Academic Advisors
Dr. Knighten

Frequency

Goal

Route

Weekly

Email, zoom, phone
calls

Co-Chair/Second Reader

As needed

Review project status, discuss
barriers and updates, share
progress
To received feedback from
draft prospectus

Monthly

Review project status, request
support as needed

Face-to-face, Emails

Twice a
week

Review Project from clinical
perspective strategize about
barriers and facilitators,
provide updates
Review Project from a Primary
Care perspective, strategize
about barriers and facilitators,
provide updates

Email and
conference calls

Discuss data collection
methodology and analysis plan
Review project status

Face-to-face

Discuss development and
launching of patient
educational Toolkit

Phone conference
and face-to-face

Project Sponsors
Executive Leadership Team
(to include the Director, Chief
of Staff, Chief Nurse
Executive)
Dr. J. Moates (Team CoLeader)

Dr. Huie (Director, Primary
Care)

Monthly

Site (Birmingham VA Medical Center)
Dr. R. Moore (Mentor)
BiMonthly
Dr. B. Roop (PharmD)
Monthly
Project Site Nurse Educator
J. Falkner
Twice a
week

Email, zoom if
necessary

Email and
conference calls

Face-to-face
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Appendix K
Cost-Benefit Analysis
Opioid Safety SMA Program
SALARY COST

Year 1

Medical Doctor (MD)

$

1,848.00 $

1,884.96 $

1,922.66

Pharmacist (PharmD)

$

1,020.00 $

1,040.40 $

1,061.21

Registered Nurse (RN)

$

540.00 $

550.80 $

561.82

Licensed Practical Nurse (LPN)

$

372.00 $

379.44 $

387.03

Medical Service Assistant (MSA)
Other Cost

$

324.00 $

330.48 $

337.09

Training

$

5,496.00 $

6,008.82 $

6,129.00

Supplies

$

53.00

54.06 $

55.14

Cumulative Cost
Benefit/Cost Avoidance

$

9,653.00

$ 10,248.96 $ 10,453.94

Cost avoidance from primary care office visit

$ 60,000.00

$ 61,200.00 $ 62,224.00

Cumulative Cost/Benefit

$ 50,347.00

$ 50,951.04 $ 51,970.06

Assumptions
2% Cost of living adjustment annually
2% Annual Increase in Training/Supply Costs
Equal number of patients in SMA and Office groups

Year 2

$

Year 3
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CQI Method
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Appendix M
Patient Report Outcomes Measurement Instrument
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Appendix N
My Health Report Card
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Appendix O
Data Collection Tool
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Appendix P
USF Statement of Determination
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Appendix Q
Signed Statement of Non-Research Determination Form

Student Name: Sherry L. Cox
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Appendix R
Letter of Support
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Appendix S
Implementation Guide Index
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Appendix T
Signage
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Appendix U
Program Flyer

A WHOLE HEALTH APPROACH FOR REDUCING
OPIOID RELIANCE
What is Whole Health?
Whole Health is an approach centered around what matters to you, not what is the matter with you. It
uses group sessions to introduce self-care techniques like mindfulness and yoga. These techniques help
you take charge of your health and well-being and live life to the fullest.
How Will This Help Me?
The Whole Health System Model includes key
elements that focus on:
Me: It begins with you, the “Me” at the
center. Your story is unique and your
whole health begins with what matters
to you
Self Care: You have the power to
impact your well-being. Whole Health
provides the support you need to
make the changes you want
Professional Care: Your health care
team is here to help
Community: Friends, family, and others
who support you on your journey

WANT TO KNOW
MORE?

ct

